<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">94073</article-id><article-id pub-id-type="doi">10.7554/eLife.94073</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.94073.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Expanding the <italic>Drosophila</italic> toolkit for dual control of gene expression</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-262972"><name><surname>Zirin</surname><given-names>Jonathan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0003-8242-5044</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-342845"><name><surname>Jusiak</surname><given-names>Barbara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6439-0456</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-342846"><name><surname>Lopes</surname><given-names>Raphael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-130760"><name><surname>Ewen-Campen</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195028"><name><surname>Bosch</surname><given-names>Justin A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8499-1566</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-342847"><name><surname>Risbeck</surname><given-names>Alexandria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-342848"><name><surname>Forman</surname><given-names>Corey</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-342849"><name><surname>Villalta</surname><given-names>Christians</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9774"><name><surname>Hu</surname><given-names>Yanhui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-300903"><name><surname>Perrimon</surname><given-names>Norbert</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7542-472X</contrib-id><email>perrimon@genetics.med.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Genetics, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>Department of Physiology and Biophysics, University of California, Irvine</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>04</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP94073</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-11-03"><day>03</day><month>11</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-10-28"><day>28</day><month>10</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.15.553399"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-12-19"><day>19</day><month>12</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.94073.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-08"><day>08</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.94073.2"/></event></pub-history><permissions><copyright-statement>© 2023, Zirin et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zirin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-94073-v1.pdf"/><abstract><p>The ability to independently control gene expression in two different tissues in the same animal is emerging as a major need, especially in the context of inter-organ communication studies. This type of study is made possible by technologies combining the GAL4/UAS and a second binary expression system such as the LexA system or QF system. Here, we describe a resource of reagents that facilitate combined use of the GAL4/UAS and a second binary system in various <italic>Drosophila</italic> tissues. Focusing on genes with well-characterized GAL4 expression patterns, we generated a set of more than 40 LexA-GAD and QF2 insertions by CRISPR knock-in and verified their tissue specificity in larvae. We also built constructs that encode QF2 and LexA-GAD transcription factors in a single vector. Following successful integration of this construct into the fly genome, FLP/FRT recombination is used to isolate fly lines that express only QF2 or LexA-GAD. Finally, using new compatible shRNA vectors, we evaluated both LexA and QF systems for in vivo gene knockdown and are generating a library of such RNAi fly lines as a community resource. Together, these LexA and QF system vectors and fly lines will provide a new set of tools for researchers who need to activate or repress two different genes in an orthogonal manner in the same animal.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>In order for researchers to understand how organisms develop and function, they often switch specific genes on or off in certain tissues or at selected times. This can be achieved using genetic tools called binary expression systems. In the fruit fly – a popular organism for studying biological processes – the most common is the GAL4/UAS system.</p><p>In this system, a protein called GAL4 is expressed in a specific organ or tissue where it activates a UAS element – a genetic sequence that is inserted in front of the gene that is to be switched on. This can also include genes inserted into the fruit fly encoding fluorescent proteins or stretches of DNA coding for factors that can silence specific genes. For example, fruit flies expressing GAL4 protein specifically in nerve cells and a UAS element in front of a gene for a fluorescent protein will display fluorescent nerve cells, which can then be examined using fluorescence microscopy.</p><p>Studying how organs communicate with one other can require controlled expression of multiple genes at the same time. In fruit flies, other binary expression systems that are analogous to the GAL4/UAS system (known as LexA/LexAop and QF/QUAS) can be used in tandem. For example, to study gut-brain communication, the GAL4/UAS system might be used to switch on the gene for an insulin-like protein in the gut, with one of the other systems controlling the expression of its corresponding receptor in the brain. However, these experiments are currently difficult because, while there are thousands of GAL4/UAS genetic lines, there are only a few LexA/LexAop and QF/QUAS genetic lines.</p><p>To address this lack of resources, Zirin et al. produced a range of genetically engineered fruit flies containing the LexA/LexAop and QF/QUAS binary expression systems. The flies expressed LexA or QF in each of the major fly organs, including the brain, heart, muscles, and gut. A fluorescent reporter gene linked to the LexAop or QUAS elements, respectively, was then used to test the specificity to single organs and compare the different systems. In some organs the LexA/LexAop system was more reliable than the QF/QUAS system. However, both systems could be successfully combined with genetic elements to switch on a fluorescent reporter gene or switch off a gene of interest in the intended organ.</p><p>The resources developed by Zirin et al. expand the toolkit for studying fruit fly biology. In future, it will be important to understand the differences between GAL4, LexA and QF systems, and to increase the number of fruit fly lines containing the newer binary expression systems.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>LexA</kwd><kwd>QF</kwd><kwd><italic>Drosophila</italic></kwd><kwd>GAL4</kwd><kwd>CRISPR</kwd><kwd>inter-organ communication</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>5P41GM132087</award-id><principal-award-recipient><name><surname>Zirin</surname><given-names>Jonathan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>5R24OD030002</award-id><principal-award-recipient><name><surname>Zirin</surname><given-names>Jonathan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001021</institution-id><institution>Damon Runyon Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>DRG-2258-16</award-id><principal-award-recipient><name><surname>Bosch</surname><given-names>Justin A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32GM007748</award-id><principal-award-recipient><name><surname>Bosch</surname><given-names>Justin A</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A CRISPR knock-in approach enables the efficient generation of tissue-specific LexA and QF driver lines which can simultaneously control gene expression in multiple tissues.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><sec id="s1-1"><title>Combinatorial binary systems</title><p>Most reagents available for loss-of-function (LOF) and gain-of-function studies using RNAi or CRISPR rely on GAL4/UAS-mediated expression (<xref ref-type="bibr" rid="bib5">Brand and Perrimon, 1993</xref>; <xref ref-type="bibr" rid="bib11">Dietzl et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Perkins et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Zirin et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Port and Boutros, 2022</xref>). However, some studies, such as the study of intercellular or inter-organ communication, require the simultaneous use of two independent binary transcriptional systems. For example, dual expression systems have been used to study how a <italic>Drosophila</italic> insulin-like peptide released from the wing primordium communicates with the brain to control organ growth (<xref ref-type="bibr" rid="bib9">Colombani et al., 2015</xref>), analyze signaling from olfactory neurons to blood cells (<xref ref-type="bibr" rid="bib38">Shim et al., 2013</xref>), independently manipulate ligand-producing and ligand receiving cells (<xref ref-type="bibr" rid="bib43">Yagi et al., 2010</xref>), and visualize interactions between clonal cell populations in tissues (<xref ref-type="bibr" rid="bib3">Bosch et al., 2015</xref>). Based on the need to simultaneously manipulate different sets of cells in a given tissue, the LexA/LexAop system (<xref ref-type="bibr" rid="bib23">Lai and Lee, 2006</xref>) and the QF/QUAS system (<xref ref-type="bibr" rid="bib34">Potter et al., 2010</xref>; <xref ref-type="bibr" rid="bib35">Potter and Luo, 2011</xref>) have been developed. There have been no systematic studies comparing the two systems, with only anecdotal evidence to support one system over the other.</p><p>The numbers of available LexA and QF fly lines with tissue-specific expression domains are far lower than that represented by the thousands of GAL4 enhancer lines, which have been developed using various approaches over the past 25 years. The largest existing set of LexA system driver lines were produced by the Janelia FlyLight Project and Vienna Tiles Project (<xref ref-type="bibr" rid="bib16">Jenett et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Tirian and Dickson, 2017</xref>). However, these lines were developed primarily for nervous system expression. Although they are often expressed in other tissues, they are not well suited for experiments targeting non-neuronal cell types. Furthermore, the FlyLight lines use a p65 transcriptional activation domain and therefore are not compatible with the GAL80 temperature-sensitive GAL4 repression system. A second large collection of ~180 LexA-based enhancer trap fly stocks has been generated (the StanEx collection) (<xref ref-type="bibr" rid="bib21">Kockel et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Kockel et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Kim et al., 2023</xref>). On average, each StanEx line expresses LexA activity in five distinct cell types, with only one line showing expression in just one tissue, unfortunately limiting usefulness of these reagents (<xref ref-type="bibr" rid="bib21">Kockel et al., 2016</xref>). These findings are consistent with prior studies indicating that enhancers very rarely produce expression patterns that are limited to a single cell type in a complex organism (<xref ref-type="bibr" rid="bib16">Jenett et al., 2012</xref>). Regarding the Q system, there are 101 total QF lines available from the Bloomington <italic>Drosophila</italic> Stock Center (BDSC). As the original QF can be toxic when expressed at high levels (<xref ref-type="bibr" rid="bib34">Potter et al., 2010</xref>), second-generation QF2 and QF2w, which are much less toxic and can be expressed broadly in vivo, were generated (<xref ref-type="bibr" rid="bib36">Riabinina et al., 2015</xref>). Among the 51 QF2 and QF2w lines available at BDSC, most are expressed in the brain, with relatively few of these drivers expressed specifically in other tissues. Thus, there remains an unmet need for more LexA and QF drivers with tissue-specific expression patterns. Furthermore, there are only ~260 LexA driver-compatible LexAop and ~130 QF driver-compatible QUAS stocks available at BDSC. The vast majority of these are to induce expression of fluorescent reporter genes, rather than molecular genetic reagents such as shRNAs for RNAi. This lack of fly stock reagents dramatically slows down studies that require two independent binary transcriptional systems, as custom fly stock reagents must be made by individual groups.</p></sec><sec id="s1-2"><title>Rapid and efficient generation of driver lines by CRISPR-Cas9</title><p>Several methods have been developed to generate new drivers with well-established tissue-specific patterns. However, these methods require either de novo generation of new driver lines, as for the integrase swappable in vivo targeting element (InSITE) system (<xref ref-type="bibr" rid="bib15">Gohl et al., 2011</xref>), or PhiC31-induced insertion of a transcription factor cassette into an existing minos-mediated integration cassette genomic insertion (<xref ref-type="bibr" rid="bib40">Venken et al., 2011</xref>; <xref ref-type="bibr" rid="bib10">Diao et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Gnerer et al., 2015</xref>). CRISPR/Cas9 technology now makes it possible to knock-in a transcriptional activator into any locus. Some groups have also recently described tools to swap QF or LexA into the GAL4 coding region of existing GAL4 enhancer trap lines (<xref ref-type="bibr" rid="bib26">Lin and Potter, 2016</xref>; <xref ref-type="bibr" rid="bib6">Chang et al., 2022</xref>; <xref ref-type="bibr" rid="bib19">Karuparti et al., 2023</xref>). The conversion can be performed through genetic crosses; however, the frequency of conversion can vary greatly among different GAL4 lines, and many such swaps do not fully reproduce the original GAL4 expression patterns (<xref ref-type="bibr" rid="bib7">Chen et al., 2019</xref>).</p><p>Despite these techniques, and the growing collection of LexA-GAD and QF2 lines, progress has been slow, and the choice of tissues depends on the specific interests of individual labs. Here, we describe the efforts of the Transgenic RNAi Project (TRiP) to facilitate combinatorial studies by building reagents that can be used alongside GAL4/UAS in a variety of tissues. Focusing on genes with well-characterized GAL4 expression patterns, we targeted 23 genes to produce 44 new highly tissue-specific LexA-GAD and QF2 driver lines by CRISPR-mediated homology-directed repair. We chose to use LexA with the GAL4 activation domain, rather than the p65 or VP16 activation domains to allow for temporal control by the temperature-sensitive GAL4 repressor, GAL80 (<xref ref-type="bibr" rid="bib23">Lai and Lee, 2006</xref>; <xref ref-type="bibr" rid="bib31">Pfeiffer et al., 2010</xref>). We chose to use QF2 variant over the original QF, to avoid the toxicity reported for the latter (<xref ref-type="bibr" rid="bib36">Riabinina et al., 2015</xref>). Like GAL80-based modulation of LexA-GAD, QF2 activity can also be regulated temporally by expressing QS, a QF repressor. QS repression of QF can be released by feeding flies quinic acid (<xref ref-type="bibr" rid="bib37">Riabinina and Potter, 2016</xref>). Each knock-in was rigorously genotyped, and the expression pattern verified by imaging. Thus, we can systematically compare LexA-GAD vs QF2 activators inserted at precisely the same position in the genome. In addition to the new fly stocks, we provide a new set of vectors and protocols to efficiently generate LexA-GAD and/or QF2 drivers. This includes constructs that encode QF2 and LexA-GAD transcription factors in a single vector, with each coding sequence flanked by FRT sites. Following successful integration into the fly genome, the vector generates a driver in which a target gene expresses both QF2 and LexA-GAD. If desired, one of the two coding regions can then be excised with Flp, resulting in flies that express only QF2 or LexA-GAD. Furthermore, we evaluated both QF2 and LexA-GAD systems for in vivo gene knockdown and are generating a compatible library of transgenic shRNA lines in our custom QUAS and LexAop vectors as a community resource. Together, these QF2/LexA-GAD and QUAS/LexAop vectors and fly lines will provide a new set of tools for researchers who need to activate or repress two different genes in an orthogonal manner in the same animal.</p></sec></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Strategy for CRISPR knock-in of T2A-LexA-GAD and T2A-QF2</title><p>We made each genetic driver line by inserting T2A-LexA-GAD or T2A-QF2 in the coding sequence of a target gene. We have previously reported the CRISPaint method to insert T2A-GAL4 into any gene using homology-independent repair (<xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>). Using this method, we showed robust gene-specific integration of donor plasmids in the fly germ line and successfully generated new driver lines. However, because of the high probability of indels at the insertion site, we opted to use traditional CRISPR homology-directed repair to insert the T2A-LexA-GAD and T2A-QF2 into the genome. We first modified the CRISPaint donor vectors to produce pHDR-T2A-LexA-GAD-Hsp70-3xP3-RFP and pHDR-T2A-QF2-Hsp70-3xP3-RFP, which contain the transcriptional activators followed by Hsp70 terminators. We opted to use the Hsp70 3’UTR, as opposed to SV40 3’UTR, because it is comparatively weaker and may avoid toxicity due to overexpression of LexA-GAD or QF2. We also constructed pHDR-T2A-QF2-T2A-LexA-GAD-3xP3-RFP, which contains both activators flanked by FRT sites followed by SV40 terminator (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). All the vectors contain a 3XP3-RFP transformation marker gene flanked by loxP sites. These vectors are compatible with two different cloning methods for making a CRISPR donor plasmid. In the long homology arm (HA) method (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), ~1000 bp HAs are amplified from genomic DNA and inserted into the donor plasmid by Gibson assembly. A separate target-gene-specific guide RNA is cloned into a U6 promoter expression vector such as pCFD3 (<xref ref-type="bibr" rid="bib32">Port et al., 2014</xref>). In the ‘drop-in’ cloning method (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="bibr" rid="bib18">Kanca et al., 2022</xref>), a company synthesizes and clones a plasmid that contains all of the necessary features for CRISPR HDR plus a cloning site to allow ligation of T2A-LexA-GAD, T2A-QF, or T2A-LexA-GAD-T2A-QF fragments in a single step to produce the donor plasmid.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Strategy for CRISPR knock-in of T2A-LexA-GAD and T2A-QF2.</title><p>(<bold>A</bold>) Donor vectors for knock-in. pHDR-T2A-LexA-GAD-Hsp70-3xP3-RFP and pHDR-T2A-QF2-Hsp70-3xP3-RFP contain T2A-LexA-GAD or QF2 transcriptional activators followed by HSP70 terminators. pHDR-T2A-QF2-T2A-LexA-GAD-3xP3-RFP contains both activators flanked by FRT sites followed by SV40 terminator. All the vectors contain a 3XP3-RFP transformation marker flanked by loxP sites. (<bold>B</bold>) Long homology arm cloning method. ~1000 bp homology arms are amplified from genomic DNA and inserted into the AscI and SacI sites by Gibson assembly. A separate target-gene-specific guide RNA is cloned into U6 promoter expression vector such as pCFD3. (<bold>C</bold>) Drop-in cloning method. Based on the gRNA-int200 method previously described (<xref ref-type="bibr" rid="bib18">Kanca et al., 2022</xref>). A company synthesizes and clones a DNA fragment into the pUC57_Kan_gw_OK2 vector. The resulting plasmid contains the following elements: (1) two guide RNAs under the control of a U6 promoter, one (gRNA1) targeting the vector (pink arrows) to linearize the homology donor in vivo, and another (gRNA<sup>geneX</sup>) targeting the gene of interest; (2) a tRNA sequence to allow liberation of the individual guides by the endogenous tRNA processing machinery; (3) 200 bp short homology arms; and (4) BbsI and SacI cloning sites. The AscI/SacI T2A-LexA-GAD, T2A-QF, or T2A-LexA-GAD-T2A-QF fragments can then be ligated in a single directional cloning step into the BbsI/SacI sites to produce the donor plasmid. (<bold>D</bold>) T2A-LexA-GAD and (<bold>E</bold>) T2A-QF2 knock-in strategy. CRISPR-based HDR causes integration of the T2A-LexA-GAD or T2A-QF2 in the most 5’ coding exon common to all or most isoforms, resulting in expression of the activators under control of the endogenous gene regulatory region. The knock-in also produces a truncated endogenous protein and thus a strong loss-of-function allele.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig1-v1.tif"/></fig><p>For our targets, we selected a set of genes with tissue-specific expression patterns encompassing most of the major organs of the fly (<xref ref-type="table" rid="table1">Table 1</xref>). When possible, we selected genes which had a previously characterized GAL4 insertion, and strong evidence of tissue specificity (e.g. from publicly available scRNAseq, in situ, and immunohistochemistry). Once the donors/guides were cloned, they were injected into Cas9-expressing fly embryos to induce CRISPR-based HDR of the T2A-LexA-GAD or T2A-QF2 (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). We selected integration sites in the most 5’ coding exon common to all or most isoforms, resulting in expression of the activators under control of the endogenous gene regulatory regions. The knock-in also produces a truncated endogenous protein and thus a predicted strong LOF allele. To verify the knock-ins, we PCR-amplified the genomic regions flanking the insertion sites and confirmed that the insertions were seamless and in-frame. Most of our knock-in stocks were made with the long HA method, but we transitioned to the drop-in method as this technology became available. As <xref ref-type="table" rid="table1">Table 1</xref> shows, we were able to successfully generate knock-ins into nearly all the target genes using these methods.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>T2A-LexA-GAD and T2A-QF2 knock-in lines.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Target tissue</th><th align="left" valign="bottom">Target gene (name)</th><th align="left" valign="bottom">QF2</th><th align="left" valign="bottom">This paper</th><th align="left" valign="bottom">3XP3 removed</th><th align="left" valign="bottom">Others at BDSC</th><th align="left" valign="bottom">LexA-GAD</th><th align="left" valign="bottom">This paper</th><th align="left" valign="bottom">3XP3 removed</th><th align="left" valign="bottom">Others at BDSC</th></tr></thead><tbody><tr><td align="left" valign="bottom">Ubiquitous</td><td align="left" valign="bottom"><italic>da</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Germline</td><td align="left" valign="bottom"><italic>vas</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Muscle</td><td align="left" valign="bottom"><italic>Mef2</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">66469</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">97530</td></tr><tr><td align="left" valign="bottom">Muscle</td><td align="left" valign="bottom"><italic>bt</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Pan-neuronal</td><td align="left" valign="bottom"><italic>elav</italic><xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">66466</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Glia</td><td align="left" valign="bottom"><italic>repo</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">66477</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">97535</td></tr><tr><td align="left" valign="bottom">Insulin-producing cells</td><td align="left" valign="bottom"><italic>Ilp2 (regulatory region)</italic><xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Fat</td><td align="left" valign="bottom"><italic>apolpp</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Trachea</td><td align="left" valign="bottom"><italic>btl</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Heart</td><td align="left" valign="bottom"><italic>Hand</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Enocyte</td><td align="left" valign="bottom"><italic>CG9458</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Enocyte</td><td align="left" valign="bottom"><italic>CG17560</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Salivary gland</td><td align="left" valign="bottom"><italic>Sgs3</italic><xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Prothoracic gland</td><td align="left" valign="bottom"><italic>phtm</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Midgut</td><td align="left" valign="bottom"><italic>mex1</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Adult midgut enterocyte</td><td align="left" valign="bottom"><italic>Myo31DF</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Hemocyte</td><td align="left" valign="bottom"><italic>Hml</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">66468</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Hemocyte</td><td align="left" valign="bottom"><italic>He</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Crystal cell</td><td align="left" valign="bottom"><italic>PPO1</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Lamellocyte</td><td align="left" valign="bottom"><italic>PPO3</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Posterior segment</td><td align="left" valign="bottom"><italic>hh</italic><xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">97536</td></tr><tr><td align="left" valign="bottom">Wing pouch/hinge</td><td align="left" valign="bottom"><italic>nub</italic></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">No</td></tr><tr><td align="left" valign="bottom">Imaginal disc A/P boundary</td><td align="left" valign="bottom"><italic>dpp (regulatory region)</italic><xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">No</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Constructs were cloned using the drop-in method. All others were cloned by PCR of long homology arms.</p></fn><fn id="table1fn2"><label>†</label><p>Constructs were cloned into double driver vectors.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Specificity of T2A-LexA-GAD and T2A-QF2 knock-in lines</title><p>Next, we tested the specificity of the knock-in driver lines in the third instar larva (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Each T2A-LexA-GAD and T2A-QF2 knock-in line was crossed to a LexAop-GFP and QUAS-GFP reporter, respectively. Note that most of the lines are highly tissue-specific and are comparable between the LexA-GAD and QF2 knock-ins. Insertions in the <italic>daughterless</italic> gene <italic>(da)</italic> are an exception, as the T2A-LexA-GAD (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), but not the T2A-QF2 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), gives the expected ubiquitous expression pattern. Similarly, for insertions in the <italic>nubbin</italic> gene <italic>(nub)</italic> the T2A-LexA-GAD (<xref ref-type="fig" rid="fig2">Figure 2LL</xref>), but not the T2A-QF2 (<xref ref-type="fig" rid="fig2">Figure 2MM</xref>), gives the expected expression in the wing imaginal disc. In both cases, T2A-QF is expressed in the correct tissues, but incompletely. Even with these exceptions, the patterns are remarkably consistent between the T2A-LexA-GAD and T2A-QF2 knock-in lines overall.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tissue specificity of T2A-LexA-GAD and T2A-QF2 knock-ins.</title><p>(<bold>A–KK</bold>) T2A-LexA-GAD knock-in lines crossed to a LexAop-GFP reporter and T2A-QF2 knock-in lines crossed to a QUAS-GFP reporter. Panels show third instar larva. GFP shows the driver line expression pattern. RFP shows the 3XP3 transformation marker, which labels the posterior gut and anal pads of the larva. Gene names and tissues are on the left. We failed to obtain LexA-GAD knock-ins for <italic>Mef2</italic> (<bold>E</bold>) and <italic>He</italic> (DD). (LL–MM) Third instar imaginal disc from the insertions in the <italic>nubbin (nub</italic>) gene. Note that most of the lines are highly tissue-specific and are comparable between the LexA-GAD and QF2 knock-ins. Insertions in the <italic>daughterless</italic> gene (<italic>da) and nub</italic> are an exception, as the T2A-LexA-GAD, but not the T2A-QF2, gives the expected expression pattern. Insertions in the gut-specific genes <italic>mex1</italic> (<bold>X–Y</bold>) and <italic>Myo31Df</italic> (<bold>Z–AA</bold>) also differed between the LexA-GAD and QF2 drivers.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig2-v1.tif"/></fig><p>Our donor plasmids contain the transgenesis marker 3XP3-RFP, which expresses red fluorescence in the larval gut and anal pad, and the adult eye (<xref ref-type="bibr" rid="bib1">Berghammer et al., 1999</xref>). Like our previous knock-ins using the CRISPaint method (<xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>), we sometimes observed LexA-Gad or QF2 expression in the larval anal pad and gut, coincident with expression of RFP. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows one such example in the <italic>repo</italic> gene, where T2A-QF2 is expressed in the expected glial cells, but also misexpressed in RFP positive cells. Interestingly, this influence of the 3XP3-RFP is not observed in T2A-LexA-GAD <italic>repo</italic> knock-in animals (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Conversely, in the <italic>breathless (btl)</italic> gene, we observe misexpression of LexA-GAD, but not QF2 in RFP positive cells (<xref ref-type="fig" rid="fig2">Figure 2M and N</xref>). Importantly, when we removed the 3XP3-RFP cassette in the repo knock-in by cre-lox recombination, misexpression of QF2 in the gut and anal pad was completely eliminated, while the glial expression remained (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We therefore have removed or are in the process of removing the 3XP3-RFP marker from all the knock-in stocks. Currently, we have successfully removed it from 32 of the 41 driver lines that used this marker (<xref ref-type="table" rid="table1">Table 1</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>3XP3-RFP can cause misexpression of T2A-LexA-GAD or T2A-QF2.</title><p>(<bold>A</bold>) T2A-QF2-3XP3-RFP in the <italic>repo</italic> gene crossed to a QUAS-GFP reporter. In third instar larva, the reporter is expressed in the expected glial cells, but also misexpressed in gut and anal pad (yellow asterisk). (<bold>B</bold>) T2A-QF2 in the <italic>repo</italic> gene with the 3XP3-RFP removed by Cre-Lox recombination, crossed to a QUAS-GFP reporter. Removal of 3XP3-RFP eliminated gut and anal pad misexpression and did not affect glial cell expression (white arrowheads).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>T2A-QF2-T2A-LexA-GAD double driver lines</title><p>To make the T2A-LexA-GAD or T2A-QF2 knock-ins described above, each donor plasmid must be individually cloned and injected into embryos. We reasoned that by combining both drivers into a single construct, we could halve the number of injections, one of the most labor-intensive and expensive parts of the process. For this combined expression of LexA-GAD and QF2 transcription factors, we built two types of vectors: (1) a CRISPR donor version, pHDR-T2A-QF2-T2A-LexA-GAD-3xP3-RFP, which is used to insert the cassette into an endogenous locus of interest (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), and (2) a phiC31-attB version, pMCS-T2A-QF2-T2A-LexA-GAD-WALIUM20, which is used to clone an enhancer fragment of interest and is then integrated into an attP site in the fly’s genome (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Note that the phiC31-attB-compatible constructs use mini-white, not 3XP3-RFP, as a marker gene. Using these vectors, we generated CRISPR knock-ins into the <italic>elav</italic> and <italic>hedgehog (hh)</italic> genes and enhancer lines for the <italic>decapentaplegic (dpp)</italic> and <italic>insulin-like peptide 2 (Ilp2)</italic> (<xref ref-type="fig" rid="fig4">Figure 4F</xref>) genes. The <italic>elav</italic> knock-in (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) expressed both T2A-QF2 and T2A-LexA-GAD in the expected pattern in the larval nervous system. However, we did see some weak non-specific expression of T2A-LexA-GAD in the somatic muscles. The <italic>hh</italic> knock-in (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) expressed both T2A-QF2 and T2A-LexA-GAD in the expected pattern in the posterior of the imaginal discs. However, we observed that T2A-QF2, but not T2A-LexA-GAD, was restricted from the wing pouch, similar to the individual <italic>nub</italic> knock-ins (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="fig" rid="fig2">Figure 2LL–MM</xref>). As expected, the <italic>dpp</italic> enhancer (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) directed expression of both T2A-QF2 and T2A-LexA-GAD along the anterior/posterior margin of the wing imaginal disc. Again, however, T2A-QF was much reduced in the wing pouch. Finally, the <italic>Ilp2</italic> enhancer (<xref ref-type="fig" rid="fig4">Figure 4F</xref>) directed expression of both T2A-QF2 and T2A-LexA-GAD very specifically in the insulin-producing cells of the larval brain. Taken together, these results show that the double driver constructs can effectively drive expression of both activators simultaneously in the target tissue, with the caveat that T2A-QF2 does not express well in the wing pouch.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>T2A-QF2-T2A-LexA-GAD double driver lines.</title><p>(<bold>A</bold>) CRISPR-based HDR strategy for integration of the T2A-QF2-T2A-LexA-GAD-3XP3 in the most 5’ coding exon common to all or most isoforms, resulting in expression of both activators under control of the endogenous gene regulatory region. The knock-in also produces a truncated endogenous protein and thus a strong loss-of-function allele. If desired, one of the two coding regions can then be excised with Flp, resulting in flies that express only QF2 or LexA-GAD. (<bold>B</bold>) Alternative strategy allows gene enhancers to be cloned upstream of of T2A-QF2-T2A-LexA-GAD. The vector backbone includes an <italic>attB</italic> site for phiC31 insertion into <italic>attP</italic> flies. (<bold>C–D</bold>) <italic>T2A-QF2-T2A-LexA-GAD</italic> knock-ins crossed to a QUAS-GFP+LexAop-mCherry double reporter line. (<bold>C</bold>) The <italic>elav<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> knock-in drives both QUAS-GFP and LexAop-mCherry in the larval brain. There is some leakiness of mCherry in the body wall muscle (arrowheads). (<bold>D</bold>) The <italic>hh<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> knock-in drives both QUAS-GFP and LexAop-mCherry in the posterior of the wing imaginal disc. GFP expression is much less than mCherry in the wing pouch (asterisks). (<bold>E–F</bold>) Enhancer-T2A-QF2-T2A-LexA-GAD lines crossed to a QUAS-GFP+LexAop-mCherry double reporter line. (<bold>E</bold>) The <italic>dpp-blk</italic> enhancer-T2A-QF2-T2A-LexA-GAD line drives both QUAS-GFP and LexAop-mCherry along the anterior/posterior boundary of the wing imaginal disc. GFP expression is much less than mCherry in the wing pouch (stars). (<bold>F</bold>) The <italic>Ilp2</italic> enhancer-T2A-QF2-T2A-LexA-GAD line drives both QUAS-GFP and LexAop-mCherry in the insulin-producing cells of the larval brain (arrows). The fat body mCherry expression (yellow arrowhead) is from leakiness of the reporter stock and does not indicate LexA-GAD activity.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig4-v1.tif"/></fig><p>Next, we attempted to derive single T2A-QF2 and T2A-LexA-GAD lines from T2A-QF2-T2A-LexA-GAD double drivers. The strategy is outlined in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. FRT3 and FRT are mutually incompatible target sites for the Flp recombinase: FRT3 can recombine with another FRT3, and FRT with FRT, but FRT3 cannot recombine with FRT. When recombined in cis, these mutually incompatible FRT target sites randomly excise one of two inserts (see <xref ref-type="bibr" rid="bib3">Bosch et al., 2015</xref>). Hence, Flp expression will result in the formation of either T2A-<sub>FRT3</sub>-LexA-GAD-<sub>FRT</sub> (caused by recombination between FRT3 sites) or T2A-<sub>FRT3</sub>-QF2-<sub>FRT</sub> (if recombination occurs between FRT sites). Both recombination products will be stable even in the presence of Flp because they now lack a pair of compatible FRT sites. This enables us to obtain the individual driver lines (QF2 and LexA-GAD) by crossing the double drivers to flies that express Flp in the germline upon heat shock. We tested this with the <italic>hh</italic> and <italic>dpp</italic> lines and observed robust generation of both T2A-QF2 and T2A-LexA-GAD from <italic>hs-Flp; T2A-QF2-T2A-LexA-GAD</italic> parents (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In the case of the <italic>hh</italic> line, 15 out of 36 heat-shocked parents gave rise to at least one T2A-LexA-GAD progeny, with a mean of 14% recombinant offspring per parent. 20 out of 36 gave rise to at least one T2A-QF2 progeny, with a mean of 9% recombinant offspring per parent. In the case of the <italic>dpp</italic> line, 31 out of 32 heat-shocked parents gave rise to at least one T2A-LexA-GAD progeny, with a mean of 30% recombinant offspring per parent. 17 out of 32 gave rise to at least one T2A-QF2 progeny, with a mean of 9% recombinant offspring per parent. We verified the recombinants by crossing to a stock containing both LexAop-mCherry and QUAS-GFP. <xref ref-type="fig" rid="fig5">Figure 5C–E</xref> shows the wing disc from the <italic>hh</italic> double driver (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), a recombinant which only expresses T2A-QF2 (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) and a recombinant which only expresses LexA-GAD (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Recombinants were also independently verified by PCR of the insertions (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>), where we observed the expected smaller band sizes in the derivative T2A-QF2 and T2A-LexA-GAD relative to the parental double driver.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Generation of single drivers from T2A-QF2-T2A-LexA-GAD knock-ins by hs-FLP.</title><p>(<bold>A</bold>) FLP/FRT recombination scheme. Flies containing both hs-FLP and a T2A-QF2-T2A-LexA-GAD knock-in are heat shocked during larval development to induce one of two mutually exclusive recombination events in their germline between either FRT or FRT3. (<bold>B</bold>) Heat shock of <italic>hsFLP; hh<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> and hsFLP; <italic>dpp<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> flies produces frequent recombinants, both T2A-QF2 and T2A-LexA-GAD. The bar graph shows the proportion of heat-shocked animals that produced at least one recombinant offspring. The dot plot shows the proportion of recombinant offspring per heat-shocked parent. Mean ± SD is indicated. (<bold>C–D</bold>) Validation of individual <italic>hh<sup>T2A-QF2</sup> and hh<sup>T2A-LexA-GAD</sup></italic> derivatives by immunofluorescence. All panels show third instar larval wing discs dissected from potential <italic>hh<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> recombinants crossed to a QUAS-GFP+LexAop-mCherry reporter line. (<bold>C</bold>) Wing disc from non-recombinant <italic>hh<sup>T2A-QF2-T2A-LexA-GAD</sup></italic> showing expression of both GFP and mCherry in the posterior of the wing disc. Note, this is the same image as shown in <xref ref-type="fig" rid="fig4">Figure 4D</xref>. (<bold>D</bold>) Wing disc from recombinant <italic>hh<sup>T2A-QF2</sup></italic> showing expression of GFP but not mCherry in the posterior of the wing disc. (<bold>E</bold>) Wing disc from recombinant <italic>hh<sup>T2A-LexA-GAD</sup></italic> showing expression of mCherry but not GFP in the posterior of the wing disc. Validation of (<bold>F</bold>) <italic>hh<sup>T2A-QF2</sup> and hh<sup>T2A-LexA-GAD</sup></italic> derivatives and (<bold>G</bold>) <italic>dpp<sup>T2A-QF2</sup> and dpp<sup>T2A-LexA-GAD</sup></italic> derivatives by PCR from genomic DNA from individual flies. In all panels, for brevity, T2A-QF2-T2A-LexAop, T2A-QF2, and T2A-LexAop, are notated as Q+L, Q(-L), and L(-Q), respectively.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Original file for the DNA gel analysis in <xref ref-type="fig" rid="fig5">Figure 5F and G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94073-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original file for the DNA gel analysis with boxes indicating the portions cropped to produce the image for <xref ref-type="fig" rid="fig5">Figure 5F and G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94073-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig5-v1.tif"/></fig></sec><sec id="s2-4"><title>TRiP LexAop and QUAS shRNA vectors produce effective gene knockdown</title><p>The TRiP has previously generated a QUAS version of our standard shRNA expression vector, pQUAS-WALIUM20 (<xref ref-type="bibr" rid="bib30">Perkins et al., 2015</xref>), containing the standard five copies of the QF-binding site (<xref ref-type="bibr" rid="bib34">Potter et al., 2010</xref>). We also generated pLexAop-WALIUM20, containing 13 LexA DNA-binding sites, previously reported to give optimal expression with minimal leakiness (<xref ref-type="bibr" rid="bib31">Pfeiffer et al., 2010</xref>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). We cloned shRNAs targeting <italic>forked (f</italic>) and <italic>ebony (e</italic>) genes into these vectors and assayed their phenotypes when crossed to ubiquitous LexA-GAD and QF2 drivers. The first driver tested was the T2A-LexA-GAD knock-in in the <italic>da</italic> gene (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), generated in this study. This produced 100% penetrant forked bristle and ebony cuticle phenotypes in the adult thorax when crossed to <italic>f</italic> (<xref ref-type="fig" rid="fig6">Figure 6E</xref>) and <italic>e</italic> (<xref ref-type="fig" rid="fig6">Figure 6H</xref>) shRNA lines, respectively. For this experiment, <italic>white (w)</italic> shRNA was used as a negative control. We did not test the T2A-QF2 knock-in in the <italic>da</italic> gene, as we have already shown that the expression pattern was not ubiquitous (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Instead, to directly compare the two systems, we used previously described ubiquitous LexA-GAD and ubiquitous QF2 (<xref ref-type="bibr" rid="bib23">Lai and Lee, 2006</xref>) under the control of <italic>αTub84B</italic> regulatory sequences. Both Tub-LexA-GAD and Tub-QF2 drivers generated knockdown phenotypes in the thorax when crossed to <italic>f</italic> and <italic>e</italic> shRNA lines. However, the Tub-LexA-GAD phenotypes were stronger than those of Tub-QF2 (<xref ref-type="fig" rid="fig6">Figure 6C–D, F–G, I–J</xref>). For example, Tub-LexA-GAD produced a fully penetrant <italic>f</italic> bristle phenotype (<xref ref-type="fig" rid="fig6">Figure 6F</xref>) while some wild-type bristles remained on the thoraces of Tub-QF2 <italic>f</italic> knockdown (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Neither Tub-LexA-GAD nor Tub-QF2 was able to achieve the strength of phenotype generated by the T2A-LexA-GAD <italic>da</italic> knock-in line (compare the darkness of the cuticle caused by <italic>e</italic> knockdown in <xref ref-type="fig" rid="fig6">Figure 6H–J</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Transgenic RNAi Project (TRiP) LexAop and QUAS shRNA vectors produce effective gene knockdown.</title><p>(<bold>A</bold>) shRNAs for knockdown or genes for overexpression were cloned into pLexAop-WALIUM20 and pQUAS-WALIUM20, derived from the TRiP WALIUM20 vector. (<bold>B–J</bold>) Dorsal view of adult fly thoraces resulting from crosses of LexAop or QUAS shRNAs to <italic>da<sup>T2A-LexA-GAD</sup></italic> (generated in this study), <italic>Tub-LexA-GAD</italic> (Bloomington <italic>Drosophila</italic> Stock Center [BDSC] 66686), or <italic>Tub-QF2</italic> (BDSC 51958). (<bold>B–C</bold>) <italic>white</italic> shRNA control produced no thoracic phenotypes in any of the crosses. (<bold>E–G</bold>) <italic>forked</italic> shRNA produced a forked bristles phenotype (white arrowheads). Note that some bristles retain a more elongated wild-type morphology with the Tub-QF2-driven <italic>forked</italic> knockdown (G, yellow asterisk). (<bold>H–J</bold>) <italic>ebony</italic> shRNA produced a darkened cuticle phenotype. The <italic>da<sup>T2A-LexA-GAD</sup></italic> driver produced the strongest phenotype (compare panel H to I and J).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94073-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>There have been previous efforts to make LexA and QF tools, but the availability of LexA-GAD and QF2 tissue-specific fly stocks remains a major resource gap, preventing the average fly researcher from performing the type of multi-tissue manipulations that are essential to advance the study of organ and tissue communication. The collection of T2A-LexA-GAD and T2A-QF2 drivers described here is unique in that it is the first to focus on covering the major organ systems of the fly. Our protocol for generating these stocks is straightforward and can be easily adapted to produce driver lines for other fly tissues. These efforts will benefit from the emergence of scRNAseq datasets, which can be used to identify target genes with highly organ or tissue-specific gene expression patterns. For example, we identified the uncharacterized genes <italic>CG9458</italic> and <italic>CG17560,</italic> as highly oenocyte-specific based on the Fly Cell Atlas Single-cell transcriptome (<xref ref-type="bibr" rid="bib25">Li et al., 2022</xref>), and the T2A-LexA-GAD and T2A-QF2 knock-ins in these genes were indeed restricted to this tissue. Our collection of T2A-LexA-GAD and T2A-QF2 and double driver vectors can be easily adapted to target any gene for CRISPR knock-in, with a high probability that the resulting line will accurately reflect the expression of the endogenous locus. The specificity achieved with this approach can also be seen in recent efforts to build collections of gene-specific T2A-Split-GAL4 and T2A-GAL4 insertions (<xref ref-type="bibr" rid="bib17">Kanca et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Chen et al., 2023</xref>; <xref ref-type="bibr" rid="bib12">Ewen-Campen et al., 2023</xref>). Our vectors are compatible with both the traditional large HA flanked cassettes and the more streamlined drop-in approach. In our hands, the drop-in cloning strategy is particularly effective, as the cloning success rate is 100%, requires little troubleshooting, has a very high knock-in rate, and only costs ~$100 to synthesize the construct (<xref ref-type="bibr" rid="bib17">Kanca et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Kanca et al., 2022</xref>).</p><p>Our results also present the opportunity to directly compare the LexA-GAD and QF2 systems. While we had no difficulty obtaining knock-ins for both types of activators, we did observe that for some target genes, the T2A-QF2 was only active in a subset of the expected gene expression pattern. In particular, we found that T2A-QF2 was difficult to express in the wing pouch. Additionally, we found that the driver expression in the gut-specific genes, <italic>mex1</italic> and <italic>Myo31Df,</italic> differed between the LexA-GAD and QF2 transformants. In both cases the LexA-GAD was more broadly expressed along the length of the gut than the QF2. It may be that toxicity is an issue, and the weaker QF2w may be a better option for generating drivers in some organs (<xref ref-type="bibr" rid="bib37">Riabinina and Potter, 2016</xref>). Alternatively, differences in the LexA-GAD and QF2 sequences, and sequence length, could impact the function of nearby gene regulatory regions. Further, we expect that there will also be differences between the expression pattern of corresponding GAL4 and the LexA-GAD/QF lines, as the latter were made by knock-in, while the former are often enhancer traps. However, based on our larval mounts and dissections, the stocks generated in this paper are highly specific to the expression pattern of the targeted genes. Importantly, our knock-in constructs contain the 3XP3-RFP cassette for screening transformants. Perhaps due to interaction between the 3XP3 promoter and the regulatory regions of the target gene, we occasionally saw misexpression of the LexA-GAD/QF2 in the 3XP3 domain. We have therefore prioritized Cre-Lox removal of the 3XP3-RFP cassette from our knock-in stocks, and advise that users of the plasmids described here likewise remove the marker, following successful knock-in.</p><p>When we compared the knockdown efficiency of shRNAs targeting <italic>forked</italic> and <italic>ebony</italic> and, we found that the TRiP 13XLexAop vector was more effective than the 5XQUAS vector, although both were able to induce knockdown. Based on these results, the TRiP is currently generating a set of ~100 LexAop shRNA lines encompassing the genes targeted by the most commonly ordered UAS shRNA stocks at the BDSC. See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for a list of all LexAop shRNA lines in production. There remains an unmet need for a single vector that would allow for UAS/LexAop/QUAS control of different shRNAs. However, recent innovations in multi-module vectors and multiplexed drug-based genetics allow researchers to more efficiently generate UAS/QUAS/lexAop transgenic fly strains (<xref ref-type="bibr" rid="bib28">Matinyan et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Wendler et al., 2022</xref>). In summary, we have generated a set of stocks, vectors, and protocols that when combined with the wide array of GAL4 lines will greatly expand the ability of <italic>Drosophila</italic> researchers to modulate gene expression in multiple tissues simultaneously.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Generation of pHDR-T2A-LexA/QF2-Hsp70-3xP3-RFP plasmids</title><p>To generate the pHDR-T2A-LexA/QF2-Hsp70-3xP3-RFP plasmids, we replaced the SV40-3’UTR present in the pCRISPaint-T2A-LexA/QF2 vector (<xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>) with the hsp70-3’UTR, using Gibson assembly (<xref ref-type="bibr" rid="bib13">Gibson et al., 2009</xref>) (NEB E2611). The hsp70-3’UTR was amplified from a pCRISPaint-GAL4-Hsp70 plasmid using the following primers: F: <named-content content-type="sequence">GTCGACTAAAGCCAAATAG</named-content>, R: <named-content content-type="sequence">AAACGAGTTTTTAAGCAAAC</named-content>, appended at the 5’ end with appropriate homologous overhangs for Gibson assembly. To remove the two endogenous SacI sites in the QF2 coding sequence, we used Gibson assembly featuring primers that introduce synonymous SNPs which mutate the SacI-binding sites without disrupting the coding sequence (GAGCTC&gt;GAACTC).</p></sec><sec id="s4-2"><title>Cloning of T2A-LexA-GAD and T2A-QF2 donor constructs</title><p>For the long-HA cloning method, we amplified the HAs by selecting ~1000 kb upstream and downstream of the guide cut site, making sure that the left HA is in frame with the T2A, and that the ends of the primers contain Gibson overhangs matching the pHDR-T2A-LexA/QF2-Hsp70-3xP3-RFP plasmids. Amplification was always from genomic DNA from the nos-Cas9 injection stock. We used Phusion (NEB), Taq (Takara), or Q5 (NEB). In cases where the PCR product was faint, we set up eight PCR samples in parallel, combined them, concentrated them using phenol-chloroform extraction followed by ethanol precipitation, and ran the concentrated sample on a gel to obtain a bright band that was then gel-purified for use in Gibson assembly. Once the HAs were amplified, we performed Gibson assembly with the pHDR-T2A-LexA/QF2-Hsp70-3xP3-RFP plasmids digested with AscI/SacI. Guide RNAs were cloned separately in pCFD3 (<xref ref-type="bibr" rid="bib32">Port et al., 2014</xref>). We chose previously designed gRNAs from <ext-link ext-link-type="uri" xlink:href="https://www.flyrnai.org/crispr3/web/">https://www.flyrnai.org/crispr3/web/</ext-link>. Our criteria were: efficiency &gt;5, and no U6 termination site. Primer and guide sequences are in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. We designed sense and antisense oligos for each gRNA, and then annealed them together to make a ds-oligo with overhangs for cloning: we combined 1.0 µl each 100 µM sense+antisense oligo, 1.0 µl 10× T4 ligase buffer, 0.5 µl T4 polynucleotide kinase (NEB), and 6.5 µl dH<sub>2</sub>O, and incubated at 37°C 30 min followed by 5 min at 95°C and slowly cooling down to room temperature (–5°C/min). The ds-oligos were then ligated into BbsI-digested pCFD3 vector with T4 ligase (NEB). Following cloning, plasmids were verified by sequencing with primer (<named-content content-type="sequence">GCCGAGCACAATTGTCTAGAATGC</named-content>).</p><p>For the drop-in method, we followed a modified version of the protocol described elsewhere (<xref ref-type="bibr" rid="bib18">Kanca et al., 2022</xref>). Briefly, homology donor intermediate vectors were ordered from Genewiz in the pUC57 Kan_gw_OK2 vector backbone, containing the gene-specific guide sequence, 200 bp short HAs flanking the genomic cut site, and a BbsI and SacI cloning site. pHDR-T2A-LexA/QF2-Hsp70-3xP3-RFP plasmids were digested with AscI/SacI, producing a 2677 bp fragment for QF2 and the ~4.5 kb fragment for LexA-GAD, each with overhangs compatible with the pUC57 Kan_gw_OK2 BbsI/SacI overhangs. The digested pUC57 Kan_gw_OK2 backbone, containing the HAs and guides, was then ligated with the digested T2A-LexA/QF2-Hsp70-3xP3-RFP with 2.5 µl 10× T4 DNA ligase buffer (NEB B0202S) and 0.5 µl T4 DNA ligase (NEB M0202S). Sequences of the synthesized drop-in fragments are in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-3"><title>Construction of T2A-QF2-T2A-LexA-GAD double driver constructs</title><p>For combined expression of LexA-GAD and QF2 transcription factors, we built two different vectors: (1) a CRISPR donor version, which we used to insert the LexA-GAD-QF2 cassette into an endogenous locus of interest, such that the expression of lexA-GAD and QF2 is driven by endogenous regulatory sequences, and (2) a ϕC31-attB version, which is used to clone an enhancer fragment of interest and integrated into an attP site in the fly genome.</p><p>To build the pHDR-T2A-QF2-T2A-LexA-GAD-3XP3-RFP construct, we used pCRISPaint-T2A-QF2 and pCRISPaint-T2A-LexA-GAD vectors (<xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>) to assemble the the vector as follows (see also <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>):</p><list list-type="order"><list-item><p>A gBlock double-stranded DNA fragment covering the N-terminus of the QF2 ORF along with T2A, FRT3, and HAs for Gibson assembly (BJusiak-QF2-N).</p></list-item><list-item><p>Part of the QF2 ORF amplified as a PCR product off the CRISPaint-T2A-QF2 vector using BJusiak-QF2-fwd+rev primer pair.</p></list-item><list-item><p>A gBlock encoding the C-terminus of QF2 and the FRTwt-T2A-FRT3 sequence between QF2 and LexA-GAD, along with HAs for Gibson assembly (BJusiak-QF2-C).</p></list-item><list-item><p>Most of the LexA-GAD ORF, PCR-amplified off the CRISPaint-T2A-LexA-GAD template with the BJusiak-lexA1-fwd+rev primer pair.</p></list-item><list-item><p>BJusiak-FRToligo1-top+bottom, a pair of single-stranded oligos annealed to make a ds-oligo encoding the FRTwt site 3’ of LexA-GAD.</p></list-item><list-item><p>CRISPaint vector digested with ApaI+KpnI restriction enzymes.</p></list-item></list><p>gBlocks and oligos were ordered from Integrated DNA Technologies (IDT) and restriction enzymes were from NEB. The sequences of all gBlocks and oligos used to build pHDR-QF2-LexA-GAD are in Supplementary materials and methods. HAs and guides for CRISPR were cloned as described above for the T2A-LexA-GAD and T2A-QF2 single donor constructs.</p><p>We digested CRISPaint-T2A-QF2 with ApaI at 25°C in CutSmart buffer, followed by digestion with KpnI-HF at 37°C. We ran the digest on an agarose gel and purified the 4.9 kb vector backbone. We then set up the Gibson assembly:</p><list list-type="simple"><list-item><p>Vector backbone (4,938 bp) 100 ng</p></list-item><list-item><p>lexGAD PCR product (2875 bp) 117 ng 2:1 insert:vector molar ratio</p></list-item><list-item><p>QF2 PCR product (292 bp) 18 ng 3:1 insert:vector</p></list-item><list-item><p>BJusiak-QF2-N (713 bp) 44 ng 3:1 insert:vector</p></list-item><list-item><p>BJusiak-QF2-C (324 bp) 20 ng 3:1 insert:vector</p></list-item><list-item><p>FRT-ds-oligo (88 bp) 9.0 ng 5:1 insert:vector.</p></list-item></list><p>We added dH<sub>2</sub>O to 10.0 µl final volume, added 10.0 µl Gibson Assembly Mix (NEB), and incubated at 50°C for 1 hr. We transformed 5.0 µl of the Gibson assembly reaction into Top10 chemically competent <italic>Escherichia coli</italic> and plated on LB+carbenicillin, then screened <italic>E. coli</italic> colonies by PCR with the BJusiak-Qlex-test1-fwd+rev primer pair (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>), expected to give a 0.7 kb product in the presence of correctly assembled CRISPaint-QF2-lexGAD. Plasmid DNA was prepared from positive colonies using the ZymoPure midiprep kit. Restriction digest fingerprinting of the plasmid midipreps produced expected band patterns, which were verified by sequencing.</p><p>To build the pMCS-T2A-QF2-T2A-LexA-GAD-WALIUM20 construct, we performed Gibson assembly with the following fragments (see also <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>):</p><list list-type="order"><list-item><p>MCS-WAL20-START gBlock, including the MCS, hsp70 promoter, T2A-FRT3 coding sequence, and HAs for Gibson assembly;</p></list-item><list-item><p>MCS-WAL20-STOP-v2 gBlock, including the 3’ end of LexA-GAD ORF, FRT coding sequence, and STOP codon;</p></list-item><list-item><p>QF2-T2A-LexA-GAD ORF PCR-amplified with FRT-QF2-fwd+FRT-lexA-GAD-rev primer pair – used Hot-Start Q5 polymerase with GC enhancer (NEB);</p></list-item><list-item><p>WALIUM20 vector digested with BamHI+EcoRI.</p></list-item></list><p>We transformed the Gibson assembly reaction into Top10 chemically competent <italic>E. coli</italic> and plated them on LB+carbenicillin. We screened colonies with PCR using the BJusiak-Qlex-test1-fwd+rev primer pair, same as for CRISPaint-QF2-lexGAD. Positive colonies were used for plasmid preps, which were sent for Sanger sequencing (Azenta) with the QF2-seq1-rev primer (<named-content content-type="sequence">TGTTAGTGAGATCAGCGAAC</named-content> expected to read across the MCS-hsp70 region).</p><p>To make a variant pMCS-QF2-LexA-GAD-alt that lacks the Hsp70 promoter, we did Gibson assembly as above, except we replaced the MCS-WAL20-START with MCS-WAL20-START-new gBlock, which lacks the Hsp70 sequence.</p></sec><sec id="s4-4"><title>Cloning HAs into pHDR-T2A-QF2-T2A-LexA-GAD-3XP3-RFP</title><p>HAs were amplified by PCR as described above. See also <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> for the PCR primers. We then digested pHDR-T2A-QF2-T2A-LexA-GAD-3XP3-RFP separately with AscI+SaCI to release the vector backbone and with NotI+SacI to purify the T2A-QF2-T2A-lexA-GAD-3XP3-RFP fragment. We gel-purified the backbone, T2A-QF2-T2A-lexA-GAD-3XP3-RFP fragment, and the HA PCR products, and we assembled all four fragments using Gibson assembly. We used 50 ng vector backbone, twofold molar excess of T2A-QF2-T2A-lexA-GAD-3XP3-RFP, and threefold molar excess of each HA. We transformed the Gibson assembly product into Top10 chemically competent <italic>E. coli</italic>, miniprepped (QIAGEN) and verified by sequencing. Guides were cloned into pCFD3 as described above.</p></sec><sec id="s4-5"><title>Cloning large enhancer fragments into pMCS-T2A-QF2-T2A-lexA-GAD-WALIUM20</title><p><italic>Ilp2</italic>-GAL4 has been described (<xref ref-type="bibr" rid="bib42">Wu et al., 2005</xref>). The <italic>dpp-blk</italic> enhancer was described as a ‘4 kb BamHI fragment’ (<xref ref-type="bibr" rid="bib27">Masucci et al., 1990</xref>) that is 17 kb 3’ of the <italic>dpp</italic> transcribed region (<xref ref-type="bibr" rid="bib2">Blackman et al., 1987</xref>; <xref ref-type="bibr" rid="bib2">Blackman et al., 1987</xref>). The primers used to PCR these fragments, using fly genomic DNA as template, are in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. After PCR-amplifying the enhancer fragment with Q5 polymerase (+GC for <italic>Ilp2</italic>, no GC for <italic>dpp</italic>), we digested it and the destination vector with the corresponding enzymes (NotI+EcoRI for <italic>dpp-blk</italic>, PacI+EcoRI for <italic>Ilp2</italic>). We used pMCS-T2A-QF2-T2A-lexA0GAD-WALIUM20 for dpp-blk and pMCS-T2A-QF2-T2A-lexGAD-WALIUM20-alt (which lacks the hsp70 promoter) for <italic>Ilp2</italic>, since <italic>dpp-blk</italic> does not have a basal promoter, but the <italic>Ilp2</italic> enhancer does. We ligated the PCR fragments into the vectors using T4 ligase (NEB), transformed into <italic>E. coli</italic>, miniprepped (QIAGEN) and verified by sequencing.</p><p>All vectors described here that are required to produce new driver lines will be made available at Addgene.</p></sec><sec id="s4-6"><title>Cloning shRNAs</title><p>shRNAs (21 bp) were cloned into pQUAS-WALIUM20 and pLexAop-WALIUM20 vectors digested with EcoRI+XbaI, as described previously (<xref ref-type="bibr" rid="bib29">Ni et al., 2011</xref>). The oligos were as follows:</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Gene</th><th align="left" valign="bottom">Oligo forward</th><th align="left" valign="bottom">Oligo reverse</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>white</italic></td><td align="left" valign="bottom"><named-content content-type="sequence">ctagcagtCAGCGTCGTCCAGGTGCTGAAagttatattcaagcataTTCAGCACCTGGACGACGCTGgcg</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">aattcgcCAGCGTCGTCCAGGTGCTGAAtagttatattcaagcataTTCAGCACCTGGACGACGCTGactg</named-content></td></tr><tr><td align="left" valign="bottom"><italic>ebony</italic></td><td align="left" valign="bottom"><named-content content-type="sequence">ctagcagtTCCGGAGAGGTTCTTGGAGAAtagttatattcaagcataTTCTCCAAGAACCTCTCCGGAgcg</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">aattcgcTCCGGAGAGGTTCTTGGAGAAtagttatattcaagcataTTCTCCAAGAACCTCTCCGGAactg</named-content></td></tr><tr><td align="left" valign="bottom"><italic>forked</italic></td><td align="left" valign="bottom"><named-content content-type="sequence">ctagcagtTCCGACCTAATTGCCGAGCTAtagttatattcaagcataTAGCTCGGCAATTAGGTCGGAgcg</named-content></td><td align="left" valign="bottom"><named-content content-type="sequence">aattcgcTCCGACCTAATTGCCGAGCTAtagttatattcaagcataTAGCTCGGCAATTAGGTCGGAactg</named-content></td></tr></tbody></table></table-wrap><p>All transgenic lines were sequenced to confirm the identity of the shRNA.</p></sec><sec id="s4-7"><title>Fly injections</title><p>All CRISPR constructs were injected at 250 ng/µl along with 100 ng/µl gene-specific gRNA(s) where appropriate. 300 embryos from <italic>y w; iso18; attP2, nos-Cas9</italic> for genes on the X, second or fourth chromosomes and <italic>y w; attP40, nos-Cas9; iso5</italic> for genes on the third chromosome per genotype were injected as described previously (<xref ref-type="bibr" rid="bib24">Lee et al., 2018</xref>). Knock-in efficiencies were comparable to previous reports (<xref ref-type="bibr" rid="bib17">Kanca et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Kanca et al., 2022</xref>). Resulting G0 males and females were crossed individually to appropriate balancer flies for <italic>3XP3-RFP</italic> screening. Positive lines were balanced, and stocks were established. For phiC31-integration, each plasmid was injected at 50 ng/μl into <italic>y v nos-phiC31-int; attP40</italic> (for chromosome 2 insertions) or <italic>y v nos-phiC31-int; attP2</italic> (for chromosome 3 insertions). Injected male G0 flies were crossed with <italic>y w; Gla/CyO or y w; Dr e/TM3, Sb</italic> to identify transformants and remove the integrase from the X chromosome, and subsequently balanced.</p></sec><sec id="s4-8"><title>PCR validation of knock-ins</title><p>PCR primers that flank the integration site were designed for each targeted gene. These primers were used in combination with primers that bind within the inserted cassette in both orientations. 500–800 nt amplicons were amplified from genomic DNA from individual insertion lines through single fly PCR using GoTaq green master mix (Promega M7122).</p><p>All transgenic fly stocks described here will be made available at the BDSC.</p></sec><sec id="s4-9"><title>Imaging</title><p>T2A-LexA-Gad, T2A-QF2, or double driver lines were crossed to <italic>y w; Sp/CyO; LexAop-GFP (BDSC 52266), y w; QUAS-GFP/CyO (BDSC 52264), or y w; QUAS-GFP (BDSC 52264)/CyO-GFP; LexAop-RFP</italic> (BDSC 52271)<italic>/TM3</italic>. Larvae were placed in PBS and sandwiched between a slide and coverslip, then live-imaged using a Zeiss (Carl Zeiss, Thornwood, NY, USA) Stemi SVII fluorescence microscope. Wing imaginal discs from third instar larvae were dissected in PBS, fixed in 4% methanol-free formaldehyde, and permeabilized in PBT, mounted on glass slides with vectashield (H-1000; Vector Laboratories) under a coverslip, and imaged on a Zeiss 780 confocal microscope.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Methodology, Writing – original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Table listing the gene names and antisense sequence of 96 constructs cloned and injected to produce a set of transgenic LexAop-shRNA fly lines.</title></caption><media xlink:href="elife-94073-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Table listing the gene names, guide sequences, and primers for amplification of long homology arms for T2A-QF2 and T2A-LexA-GAD constructs.</title></caption><media xlink:href="elife-94073-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Sequences of DNA fragments synthesized into the pUC57 Kan_gw_OK2 vector backbone for subsequent drop-in cloning.</title></caption><media xlink:href="elife-94073-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Sequences of DNA fragments used to build pHDR-T2A-QF2-T2A-LexA-GAD and pMCS-T2A-QF2-T2A-LexA-GAD-WALIUM20.</title><p>FRT3 sequences are shown in blue and FRTwt sequences are shown in red.</p></caption><media xlink:href="elife-94073-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Primers and guide sequences for amplification of long homology arms for pHDR-T2A-QF2-T2A-LexA-GAD-3XP3-RFP constructs.</title></caption><media xlink:href="elife-94073-supp5-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Primers used to amplify large enhancers for cloning into pMCS-T2A-QF2-T2A-LexA-GAD-WALIUM20.</title><p>The dpp-blk primers have NotI and EcoRI sites for cloning into the MCS, and the Dilp2-enh primers have PacI and EcoRI sites.</p></caption><media xlink:href="elife-94073-supp6-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-94073-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The current manuscript did not generate any datasets. Raw gel image source files are provided for Figure 5.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Stephanie Mohr for her support and advice on this project. This work was supported by 5P41GM132087 and 5R24OD030002. NP is an HHMI investigator. JAB was supported by the Damon Runyon Foundation (DRG-2258-16) and a 'Training Grant in Genetics' T32 Ruth Kirschstein-National Research Service Award institutional research training grant funded through the NIH/National Institute of General Medical Sciences (T32GM007748).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berghammer</surname><given-names>AJ</given-names></name><name><surname>Klingler</surname><given-names>M</given-names></name><name><surname>Wimmer</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A universal marker for transgenic insects</article-title><source>Nature</source><volume>402</volume><fpage>370</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/46463</pub-id><pub-id pub-id-type="pmid">10586872</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackman</surname><given-names>RK</given-names></name><name><surname>Grimaila</surname><given-names>R</given-names></name><name><surname>Koehler</surname><given-names>MM</given-names></name><name><surname>Gelbart</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Mobilization of hobo elements residing within the decapentaplegic gene complex: suggestion of a new hybrid dysgenesis system in <italic>Drosophila melanogaster</italic></article-title><source>Cell</source><volume>49</volume><fpage>497</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(87)90452-1</pub-id><pub-id pub-id-type="pmid">3032458</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Tran</surname><given-names>NH</given-names></name><name><surname>Hariharan</surname><given-names>IK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CoinFLP: a system for efficient mosaic screening and for visualizing clonal boundaries in <italic>Drosophila</italic></article-title><source>Development</source><volume>142</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1242/dev.114603</pub-id><pub-id pub-id-type="pmid">25605786</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Colbeth</surname><given-names>R</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Gene knock-Ins in <italic>Drosophila</italic> using homology-independent insertion of universal donor plasmids</article-title><source>Genetics</source><volume>214</volume><fpage>75</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302819</pub-id><pub-id pub-id-type="pmid">31685521</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development</source><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1242/dev.118.2.401</pub-id><pub-id pub-id-type="pmid">8223268</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>KR</given-names></name><name><surname>Tsao</surname><given-names>DD</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Floyd</surname><given-names>JF</given-names></name><name><surname>Tay</surname><given-names>ASY</given-names></name><name><surname>Greenwald</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>Morse</surname><given-names>E</given-names></name><name><surname>Chisholm</surname><given-names>T</given-names></name><name><surname>Rankin</surname><given-names>AE</given-names></name><name><surname>Baena-Lopez</surname><given-names>LA</given-names></name><name><surname>Lantz</surname><given-names>N</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Kockel</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Park</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Transgenic <italic>Drosophila</italic> lines for LexA-dependent gene and growth regulation</article-title><source>G3: Genes, Genomes, Genetics</source><volume>12</volume><elocation-id>jkac018</elocation-id><pub-id pub-id-type="doi">10.1093/g3journal/jkac018</pub-id><pub-id pub-id-type="pmid">35100369</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y-J</given-names></name><name><surname>Chang</surname><given-names>H-H</given-names></name><name><surname>Lin</surname><given-names>S-H</given-names></name><name><surname>Lin</surname><given-names>T-Y</given-names></name><name><surname>Wu</surname><given-names>T-H</given-names></name><name><surname>Lin</surname><given-names>H-J</given-names></name><name><surname>Liou</surname><given-names>N-F</given-names></name><name><surname>Yang</surname><given-names>C-J</given-names></name><name><surname>Chen</surname><given-names>Y-T</given-names></name><name><surname>Chang</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>C-Y</given-names></name><name><surname>Chou</surname><given-names>Y-H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Differential efficacy of genetically swapping GAL4</article-title><source>Journal of Neurogenetics</source><volume>33</volume><fpage>52</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1080/01677063.2018.1564289</pub-id><pub-id pub-id-type="pmid">30939963</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y-CD</given-names></name><name><surname>Chen</surname><given-names>Y-C</given-names></name><name><surname>Rajesh</surname><given-names>R</given-names></name><name><surname>Shoji</surname><given-names>N</given-names></name><name><surname>Jacy</surname><given-names>M</given-names></name><name><surname>Lacin</surname><given-names>H</given-names></name><name><surname>Erclik</surname><given-names>T</given-names></name><name><surname>Desplan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Using single-cell RNA sequencing to generate predictive cell-type-specific split-GAL4 reagents throughout development</article-title><source>PNAS</source><volume>120</volume><elocation-id>e2307451120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2307451120</pub-id><pub-id pub-id-type="pmid">37523539</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombani</surname><given-names>J</given-names></name><name><surname>Andersen</surname><given-names>DS</given-names></name><name><surname>Boulan</surname><given-names>L</given-names></name><name><surname>Boone</surname><given-names>E</given-names></name><name><surname>Romero</surname><given-names>N</given-names></name><name><surname>Virolle</surname><given-names>V</given-names></name><name><surname>Texada</surname><given-names>M</given-names></name><name><surname>Léopold</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title><italic>Drosophila</italic> Lgr3 couples organ growth with maturation and ensures developmental stability</article-title><source>Current Biology</source><volume>25</volume><fpage>2723</fpage><lpage>2729</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.09.020</pub-id><pub-id pub-id-type="pmid">26441350</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>F</given-names></name><name><surname>Ironfield</surname><given-names>H</given-names></name><name><surname>Luan</surname><given-names>H</given-names></name><name><surname>Diao</surname><given-names>F</given-names></name><name><surname>Shropshire</surname><given-names>WC</given-names></name><name><surname>Ewer</surname><given-names>J</given-names></name><name><surname>Marr</surname><given-names>E</given-names></name><name><surname>Potter</surname><given-names>CJ</given-names></name><name><surname>Landgraf</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Plug-and-play genetic access to <italic>Drosophila</italic> cell types using exchangeable exon cassettes</article-title><source>Cell Reports</source><volume>10</volume><fpage>1410</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.01.059</pub-id><pub-id pub-id-type="pmid">25732830</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietzl</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Schnorrer</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>K-C</given-names></name><name><surname>Barinova</surname><given-names>Y</given-names></name><name><surname>Fellner</surname><given-names>M</given-names></name><name><surname>Gasser</surname><given-names>B</given-names></name><name><surname>Kinsey</surname><given-names>K</given-names></name><name><surname>Oppel</surname><given-names>S</given-names></name><name><surname>Scheiblauer</surname><given-names>S</given-names></name><name><surname>Couto</surname><given-names>A</given-names></name><name><surname>Marra</surname><given-names>V</given-names></name><name><surname>Keleman</surname><given-names>K</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A genome-wide transgenic RNAi library for conditional gene inactivation in <italic>Drosophila</italic></article-title><source>Nature</source><volume>448</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/nature05954</pub-id><pub-id pub-id-type="pmid">17625558</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewen-Campen</surname><given-names>B</given-names></name><name><surname>Luan</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Thakkar</surname><given-names>T</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>White</surname><given-names>BH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>split-intein Gal4 provides intersectional genetic labeling that is repressible by Gal80</article-title><source>PNAS</source><volume>120</volume><elocation-id>e2304730120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2304730120</pub-id><pub-id pub-id-type="pmid">37276389</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>DG</given-names></name><name><surname>Young</surname><given-names>L</given-names></name><name><surname>Chuang</surname><given-names>R-Y</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Hutchison</surname><given-names>CA</given-names><suffix>III</suffix></name><name><surname>Smith</surname><given-names>HO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title><source>Nature Methods</source><volume>6</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gnerer</surname><given-names>JP</given-names></name><name><surname>Venken</surname><given-names>KJT</given-names></name><name><surname>Dierick</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gene-specific cell labeling using MiMIC transposons</article-title><source>Nucleic Acids Research</source><volume>43</volume><elocation-id>e56</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv113</pub-id><pub-id pub-id-type="pmid">25712101</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gohl</surname><given-names>DM</given-names></name><name><surname>Silies</surname><given-names>MA</given-names></name><name><surname>Gao</surname><given-names>XJ</given-names></name><name><surname>Bhalerao</surname><given-names>S</given-names></name><name><surname>Luongo</surname><given-names>FJ</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Potter</surname><given-names>CJ</given-names></name><name><surname>Clandinin</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A versatile in vivo system for directed dissection of gene expression patterns</article-title><source>Nature Methods</source><volume>8</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1561</pub-id><pub-id pub-id-type="pmid">21473015</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenett</surname><given-names>A</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Ngo</surname><given-names>T-TB</given-names></name><name><surname>Shepherd</surname><given-names>D</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>Dionne</surname><given-names>H</given-names></name><name><surname>Pfeiffer</surname><given-names>BD</given-names></name><name><surname>Cavallaro</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Jeter</surname><given-names>J</given-names></name><name><surname>Iyer</surname><given-names>N</given-names></name><name><surname>Fetter</surname><given-names>D</given-names></name><name><surname>Hausenfluck</surname><given-names>JH</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Trautman</surname><given-names>ET</given-names></name><name><surname>Svirskas</surname><given-names>RR</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Iwinski</surname><given-names>ZR</given-names></name><name><surname>Aso</surname><given-names>Y</given-names></name><name><surname>DePasquale</surname><given-names>GM</given-names></name><name><surname>Enos</surname><given-names>A</given-names></name><name><surname>Hulamm</surname><given-names>P</given-names></name><name><surname>Lam</surname><given-names>SCB</given-names></name><name><surname>Li</surname><given-names>H-H</given-names></name><name><surname>Laverty</surname><given-names>TR</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>SD</given-names></name><name><surname>Rokicki</surname><given-names>K</given-names></name><name><surname>Safford</surname><given-names>T</given-names></name><name><surname>Shaw</surname><given-names>K</given-names></name><name><surname>Simpson</surname><given-names>JH</given-names></name><name><surname>Sowell</surname><given-names>A</given-names></name><name><surname>Tae</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zugates</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A GAL4-driver line resource for <italic>Drosophila</italic> neurobiology</article-title><source>Cell Reports</source><volume>2</volume><fpage>991</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.09.011</pub-id><pub-id pub-id-type="pmid">23063364</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanca</surname><given-names>O</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Garcia-Marques</surname><given-names>J</given-names></name><name><surname>Knight</surname><given-names>SM</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Amador</surname><given-names>G</given-names></name><name><surname>Chung</surname><given-names>H</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>W-W</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Schulze</surname><given-names>KL</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Spradling</surname><given-names>AC</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An efficient CRISPR-based strategy to insert small and large fragments of DNA using short homology arms</article-title><source>eLife</source><volume>8</volume><elocation-id>e51539</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51539</pub-id><pub-id pub-id-type="pmid">31674908</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanca</surname><given-names>O</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Tepe</surname><given-names>B</given-names></name><name><surname>Dutta</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>W-W</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>M</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Levis</surname><given-names>RW</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An expanded toolkit for <italic>Drosophila</italic> gene tagging using synthesized homology donor constructs for CRISPR-mediated homologous recombination</article-title><source>eLife</source><volume>11</volume><elocation-id>e76077</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.76077</pub-id><pub-id pub-id-type="pmid">35723254</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karuparti</surname><given-names>S</given-names></name><name><surname>Yeung</surname><given-names>AT</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Guicardi</surname><given-names>PF</given-names></name><name><surname>Han</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A toolkit for converting Gal4 into LexA and Flippase transgenes in <italic>Drosophila</italic></article-title><source>G3: Genes, Genomes, Genetics</source><volume>13</volume><elocation-id>jkad003</elocation-id><pub-id pub-id-type="doi">10.1093/g3journal/jkad003</pub-id><pub-id pub-id-type="pmid">36617215</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Rajan</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>K</given-names></name><name><surname>Govindarajan</surname><given-names>S</given-names></name><name><surname>Gulick</surname><given-names>C</given-names></name><name><surname>English</surname><given-names>E</given-names></name><name><surname>Rodriguez</surname><given-names>B</given-names></name><name><surname>Bloomfield</surname><given-names>O</given-names></name><name><surname>Nakada</surname><given-names>S</given-names></name><name><surname>Beard</surname><given-names>C</given-names></name><name><surname>O’Connor</surname><given-names>S</given-names></name><name><surname>Mastroianni</surname><given-names>S</given-names></name><name><surname>Downey</surname><given-names>E</given-names></name><name><surname>Feigenbaum</surname><given-names>M</given-names></name><name><surname>Tolentino</surname><given-names>C</given-names></name><name><surname>Pace</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>DiPrima</surname><given-names>J</given-names></name><name><surname>Syed</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Abukhadra</surname><given-names>Y</given-names></name><name><surname>Bacon</surname><given-names>I</given-names></name><name><surname>Beckerle</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Donkor</surname><given-names>NE</given-names></name><name><surname>Garberg</surname><given-names>L</given-names></name><name><surname>Harrington</surname><given-names>A</given-names></name><name><surname>Hoang</surname><given-names>M</given-names></name><name><surname>Lawani</surname><given-names>N</given-names></name><name><surname>Noori</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Parsons</surname><given-names>E</given-names></name><name><surname>Oravitan</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Molina</surname><given-names>C</given-names></name><name><surname>Richmond</surname><given-names>C</given-names></name><name><surname>Reddi</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Shugrue</surname><given-names>C</given-names></name><name><surname>Coviello</surname><given-names>R</given-names></name><name><surname>Unver</surname><given-names>S</given-names></name><name><surname>Indelicarto</surname><given-names>M</given-names></name><name><surname>Islamovic</surname><given-names>E</given-names></name><name><surname>McIlroy</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Hamad</surname><given-names>M</given-names></name><name><surname>Griffin</surname><given-names>E</given-names></name><name><surname>Ahmed</surname><given-names>Z</given-names></name><name><surname>Alla</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>P</given-names></name><name><surname>Choi</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Roderiques</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Harper</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Suhr</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Luque</surname><given-names>J</given-names></name><name><surname>Tam</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Triff</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>E</given-names></name><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Kpodonu</surname><given-names>N</given-names></name><name><surname>Dey</surname><given-names>A</given-names></name><name><surname>Ecker</surname><given-names>A</given-names></name><name><surname>Chuang</surname><given-names>M</given-names></name><name><surname>López</surname><given-names>RKS</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Stone</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>CYJ</given-names></name><name><surname>Silvestri</surname><given-names>A</given-names></name><name><surname>Orloff</surname><given-names>P</given-names></name><name><surname>Nedumaran</surname><given-names>N</given-names></name><name><surname>Zou</surname><given-names>A</given-names></name><name><surname>Ünver</surname><given-names>L</given-names></name><name><surname>Page</surname><given-names>O</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>TYT</given-names></name><name><surname>Tulloch</surname><given-names>A</given-names></name><name><surname>Hernandez</surname><given-names>A</given-names></name><name><surname>Pillai</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Chowdhury</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Mudide</surname><given-names>A</given-names></name><name><surname>Paik</surname><given-names>G</given-names></name><name><surname>Wingate</surname><given-names>A</given-names></name><name><surname>Quinn</surname><given-names>L</given-names></name><name><surname>Conybere</surname><given-names>C</given-names></name><name><surname>Baumgardt</surname><given-names>LL</given-names></name><name><surname>Buckley</surname><given-names>R</given-names></name><name><surname>Kolberg</surname><given-names>Z</given-names></name><name><surname>Pattison</surname><given-names>R</given-names></name><name><surname>Shazli</surname><given-names>AA</given-names></name><name><surname>Ganske</surname><given-names>P</given-names></name><name><surname>Sfragara</surname><given-names>L</given-names></name><name><surname>Strub</surname><given-names>A</given-names></name><name><surname>Collier</surname><given-names>B</given-names></name><name><surname>Tamana</surname><given-names>H</given-names></name><name><surname>Ravindran</surname><given-names>D</given-names></name><name><surname>Howden</surname><given-names>J</given-names></name><name><surname>Stewart</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Braniff</surname><given-names>J</given-names></name><name><surname>Fong</surname><given-names>M</given-names></name><name><surname>Gutman</surname><given-names>L</given-names></name><name><surname>Irvine</surname><given-names>D</given-names></name><name><surname>Malholtra</surname><given-names>S</given-names></name><name><surname>Medina</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>A</given-names></name><name><surname>Abromavage</surname><given-names>H</given-names></name><name><surname>Barrett</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>R</given-names></name><name><surname>Dilatush</surname><given-names>M</given-names></name><name><surname>Gaw</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Kilby</surname><given-names>H</given-names></name><name><surname>Markel</surname><given-names>E</given-names></name><name><surname>McClure</surname><given-names>K</given-names></name><name><surname>Phillips</surname><given-names>W</given-names></name><name><surname>Polaski</surname><given-names>B</given-names></name><name><surname>Roselli</surname><given-names>A</given-names></name><name><surname>Saint-Cyr</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>E</given-names></name><name><surname>Tatum</surname><given-names>K</given-names></name><name><surname>Tumpunyawat</surname><given-names>T</given-names></name><name><surname>Wetherill</surname><given-names>L</given-names></name><name><surname>Ptaszynska</surname><given-names>S</given-names></name><name><surname>Zeleznik</surname><given-names>M</given-names></name><name><surname>Pesendorfer</surname><given-names>A</given-names></name><name><surname>Nolan</surname><given-names>A</given-names></name><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Sammeta</surname><given-names>D</given-names></name><name><surname>Nicholson</surname><given-names>L</given-names></name><name><surname>Dinh</surname><given-names>GV</given-names></name><name><surname>Foltz</surname><given-names>M</given-names></name><name><surname>Vo</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>M</given-names></name><name><surname>Tokarski</surname><given-names>A</given-names></name><name><surname>Hariharan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Baziuk</surname><given-names>M</given-names></name><name><surname>Tay</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>YHM</given-names></name><name><surname>Floyd</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>A</given-names></name><name><surname>Pierre</surname><given-names>K</given-names></name><name><surname>Coppisetti</surname><given-names>N</given-names></name><name><surname>Kutam</surname><given-names>M</given-names></name><name><surname>Khurjekar</surname><given-names>D</given-names></name><name><surname>Gadzi</surname><given-names>A</given-names></name><name><surname>Gubbay</surname><given-names>B</given-names></name><name><surname>Pedretti</surname><given-names>S</given-names></name><name><surname>Belovich</surname><given-names>S</given-names></name><name><surname>Yeung</surname><given-names>T</given-names></name><name><surname>Fey</surname><given-names>M</given-names></name><name><surname>Shaffer</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Beritela</surname><given-names>G</given-names></name><name><surname>Huyghue</surname><given-names>K</given-names></name><name><surname>Foster</surname><given-names>G</given-names></name><name><surname>Durso-Finley</surname><given-names>G</given-names></name><name><surname>Thierfelder</surname><given-names>Q</given-names></name><name><surname>Kiernan</surname><given-names>H</given-names></name><name><surname>Lenkowsky</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>N</given-names></name><name><surname>Chao</surname><given-names>O</given-names></name><name><surname>L’Etoile-Goga</surname><given-names>P</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>McKinley</surname><given-names>P</given-names></name><name><surname>Read</surname><given-names>N</given-names></name><name><surname>Milberg</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Gilman</surname><given-names>I</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Kosai</surname><given-names>J</given-names></name><name><surname>Verbinsky</surname><given-names>M</given-names></name><name><surname>Belshaw-Hood</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Lobo</surname><given-names>M</given-names></name><name><surname>Tse</surname><given-names>A</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name><name><surname>Sonawane</surname><given-names>P</given-names></name><name><surname>Ngo</surname><given-names>J</given-names></name><name><surname>Zuzga</surname><given-names>S</given-names></name><name><surname>Chow</surname><given-names>L</given-names></name><name><surname>Huynh</surname><given-names>V</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Stites</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Cruz-Balleza</surname><given-names>R</given-names></name><name><surname>Pelta</surname><given-names>M</given-names></name><name><surname>Kujawski</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Standen-Bloom</surname><given-names>E</given-names></name><name><surname>Witt</surname><given-names>O</given-names></name><name><surname>Anders</surname><given-names>K</given-names></name><name><surname>Duane</surname><given-names>A</given-names></name><name><surname>Huynh</surname><given-names>N</given-names></name><name><surname>Lester</surname><given-names>B</given-names></name><name><surname>Fung-Lee</surname><given-names>S</given-names></name><name><surname>Fung</surname><given-names>M</given-names></name><name><surname>Situ</surname><given-names>M</given-names></name><name><surname>Canigiula</surname><given-names>P</given-names></name><name><surname>Dijkgraaf</surname><given-names>M</given-names></name><name><surname>Romero</surname><given-names>W</given-names></name><name><surname>Baula</surname><given-names>SK</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>I</given-names></name><name><surname>Martinez</surname><given-names>B</given-names></name><name><surname>Nuygen</surname><given-names>R</given-names></name><name><surname>Norris</surname><given-names>L</given-names></name><name><surname>Nijensohn</surname><given-names>N</given-names></name><name><surname>Altman</surname><given-names>N</given-names></name><name><surname>Maajid</surname><given-names>E</given-names></name><name><surname>Burkhardt</surname><given-names>O</given-names></name><name><surname>Chanda</surname><given-names>J</given-names></name><name><surname>Doscher</surname><given-names>C</given-names></name><name><surname>Gopal</surname><given-names>A</given-names></name><name><surname>Good</surname><given-names>A</given-names></name><name><surname>Good</surname><given-names>J</given-names></name><name><surname>Herrera</surname><given-names>N</given-names></name><name><surname>Lanting</surname><given-names>L</given-names></name><name><surname>Liem</surname><given-names>S</given-names></name><name><surname>Marks</surname><given-names>A</given-names></name><name><surname>McLaughlin</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Mohr</surname><given-names>C</given-names></name><name><surname>Patton</surname><given-names>E</given-names></name><name><surname>Pyarali</surname><given-names>N</given-names></name><name><surname>Oczon</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>D</given-names></name><name><surname>Good</surname><given-names>N</given-names></name><name><surname>Goss</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Madonia</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>V</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Vranka</surname><given-names>T</given-names></name><name><surname>Garcia</surname><given-names>D</given-names></name><name><surname>Arroyo</surname><given-names>F</given-names></name><name><surname>Morales</surname><given-names>E</given-names></name><name><surname>Camey</surname><given-names>S</given-names></name><name><surname>Cano</surname><given-names>G</given-names></name><name><surname>Bernabe</surname><given-names>A</given-names></name><name><surname>Arroyo</surname><given-names>J</given-names></name><name><surname>Lopez</surname><given-names>Y</given-names></name><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Zumba</surname><given-names>B</given-names></name><name><surname>Garcia</surname><given-names>J</given-names></name><name><surname>Vargas</surname><given-names>E</given-names></name><name><surname>Trinidad</surname><given-names>A</given-names></name><name><surname>Candelaria</surname><given-names>N</given-names></name><name><surname>Valdez</surname><given-names>V</given-names></name><name><surname>Campuzano</surname><given-names>F</given-names></name><name><surname>Pereznegron</surname><given-names>E</given-names></name><name><surname>Medrano</surname><given-names>J</given-names></name><name><surname>Gutierrez</surname><given-names>J</given-names></name><name><surname>Gutierrez</surname><given-names>E</given-names></name><name><surname>Abrego</surname><given-names>ET</given-names></name><name><surname>Gutierrez</surname><given-names>D</given-names></name><name><surname>Ortiz</surname><given-names>C</given-names></name><name><surname>Barnes</surname><given-names>A</given-names></name><name><surname>Arms</surname><given-names>E</given-names></name><name><surname>Mitchell</surname><given-names>L</given-names></name><name><surname>Balanzá</surname><given-names>C</given-names></name><name><surname>Bradford</surname><given-names>J</given-names></name><name><surname>Detroy</surname><given-names>H</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Guillermo</surname><given-names>E</given-names></name><name><surname>Manapragada</surname><given-names>A</given-names></name><name><surname>Nanula</surname><given-names>D</given-names></name><name><surname>Serna</surname><given-names>B</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Sramaty</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>B</given-names></name><name><surname>Wiggins</surname><given-names>M</given-names></name><name><surname>Dowling</surname><given-names>M</given-names></name><name><surname>Schmadeke</surname><given-names>G</given-names></name><name><surname>Cafferky</surname><given-names>S</given-names></name><name><surname>Good</surname><given-names>S</given-names></name><name><surname>Reese</surname><given-names>M</given-names></name><name><surname>Fleig</surname><given-names>M</given-names></name><name><surname>Gannett</surname><given-names>A</given-names></name><name><surname>Cain</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Oberto</surname><given-names>P</given-names></name><name><surname>Rinehart</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>E</given-names></name><name><surname>Mathis</surname><given-names>SA</given-names></name><name><surname>Joiner</surname><given-names>J</given-names></name><name><surname>Barr</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>CJ</given-names></name><name><surname>Baena-Lopez</surname><given-names>A</given-names></name><name><surname>Beatty</surname><given-names>A</given-names></name><name><surname>Collette</surname><given-names>J</given-names></name><name><surname>Smullen</surname><given-names>R</given-names></name><name><surname>Suttie</surname><given-names>J</given-names></name><name><surname>Chisholm</surname><given-names>T</given-names></name><name><surname>Rotondo</surname><given-names>C</given-names></name><name><surname>Lewis</surname><given-names>G</given-names></name><name><surname>Turner</surname><given-names>V</given-names></name><name><surname>Stark</surname><given-names>L</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Amirapu</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Lantz</surname><given-names>N</given-names></name><name><surname>Rankin</surname><given-names>AE</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kockel</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Generation of LexA enhancer-trap lines in <italic>Drosophila</italic> by an international scholastic network</article-title><source>G3: Genes, Genomes, Genetics</source><volume>13</volume><elocation-id>jkad124</elocation-id><pub-id pub-id-type="doi">10.1093/g3journal/jkad124</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kockel</surname><given-names>L</given-names></name><name><surname>Huq</surname><given-names>LM</given-names></name><name><surname>Ayyar</surname><given-names>A</given-names></name><name><surname>Herold</surname><given-names>E</given-names></name><name><surname>MacAlpine</surname><given-names>E</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Savvides</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>GE</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Clark</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A <italic>Drosophila</italic> LexA enhancer-trap resource for developmental biology and neuroendocrine research</article-title><source>G3: Genes, Genomes, Genetics</source><volume>6</volume><fpage>3017</fpage><lpage>3026</lpage><pub-id pub-id-type="doi">10.1534/g3.116.031229</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kockel</surname><given-names>Lutz</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>Ahmed</surname><given-names>Y</given-names></name><name><surname>Fidelak</surname><given-names>L</given-names></name><name><surname>Rajan</surname><given-names>A</given-names></name><name><surname>Gould</surname><given-names>EP</given-names></name><name><surname>Haigney</surname><given-names>M</given-names></name><name><surname>Ralston</surname><given-names>B</given-names></name><name><surname>Tercek</surname><given-names>RJ</given-names></name><name><surname>Galligani</surname><given-names>L</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Huq</surname><given-names>L</given-names></name><name><surname>Bhargava</surname><given-names>HK</given-names></name><name><surname>Dooner</surname><given-names>AC</given-names></name><name><surname>Lemmerman</surname><given-names>EG</given-names></name><name><surname>Malusa</surname><given-names>RF</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name><name><surname>Chung</surname><given-names>JS</given-names></name><name><surname>Gregory</surname><given-names>SM</given-names></name><name><surname>Kuwana</surname><given-names>KM</given-names></name><name><surname>Regenold</surname><given-names>JT</given-names></name><name><surname>Wei</surname><given-names>A</given-names></name><name><surname>Ashton</surname><given-names>J</given-names></name><name><surname>Dickinson</surname><given-names>P</given-names></name><name><surname>Martel</surname><given-names>K</given-names></name><name><surname>Cai</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>S</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Shepley</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chalasani</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>Aalto</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Tazawa-Goodchild</surname><given-names>E</given-names></name><name><surname>Sherwood</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>SYC</given-names></name><name><surname>Lotzkar</surname><given-names>J</given-names></name><name><surname>Michaels</surname><given-names>S</given-names></name><name><surname>Aristotle</surname><given-names>H</given-names></name><name><surname>Clark</surname><given-names>A</given-names></name><name><surname>Gasper</surname><given-names>G</given-names></name><name><surname>Xiang</surname><given-names>E</given-names></name><name><surname>Schlör</surname><given-names>FL</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Haering</surname><given-names>K</given-names></name><name><surname>Friberg</surname><given-names>J</given-names></name><name><surname>Kuwana</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Norton</surname><given-names>E</given-names></name><name><surname>Hamad</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Okeremi</surname><given-names>D</given-names></name><name><surname>diTullio</surname><given-names>H</given-names></name><name><surname>Dumoulin</surname><given-names>K</given-names></name><name><surname>Chi</surname><given-names>SYG</given-names></name><name><surname>Derossi</surname><given-names>GS</given-names></name><name><surname>Horowitch</surname><given-names>RE</given-names></name><name><surname>Issa</surname><given-names>EC</given-names></name><name><surname>Le</surname><given-names>DT</given-names></name><name><surname>Morales</surname><given-names>BC</given-names></name><name><surname>Noori</surname><given-names>A</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Hoang</surname><given-names>MN</given-names></name><name><surname>Johnson</surname><given-names>IM</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Madamidola</surname><given-names>EA</given-names></name><name><surname>Schmitt</surname><given-names>KE</given-names></name><name><surname>Byan</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Monovoukas</surname><given-names>A</given-names></name><name><surname>Kang</surname><given-names>MJ</given-names></name><name><surname>McGowan</surname><given-names>T</given-names></name><name><surname>Walewski</surname><given-names>JJ</given-names></name><name><surname>Simon</surname><given-names>B</given-names></name><name><surname>Zu</surname><given-names>SJ</given-names></name><name><surname>Miller</surname><given-names>GP</given-names></name><name><surname>Fitzpatrick</surname><given-names>KB</given-names></name><name><surname>Lantz</surname><given-names>N</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Collette</surname><given-names>J</given-names></name><name><surname>Kurtz</surname><given-names>R</given-names></name><name><surname>Duncan</surname><given-names>C</given-names></name><name><surname>Palmer</surname><given-names>R</given-names></name><name><surname>Rotondo</surname><given-names>C</given-names></name><name><surname>Janicki</surname><given-names>E</given-names></name><name><surname>Chisholm</surname><given-names>T</given-names></name><name><surname>Rankin</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An interscholastic network to generate lexa enhancer trap lines in <italic>Drosophila</italic></article-title><source>G3: Genes, Genomes, Genetics</source><volume>9</volume><fpage>2097</fpage><lpage>2106</lpage><pub-id pub-id-type="doi">10.1534/g3.119.400105</pub-id><pub-id pub-id-type="pmid">31040111</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>SL</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic mosaic with dual binary transcriptional systems in <italic>Drosophila</italic></article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>703</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1038/nn1681</pub-id><pub-id pub-id-type="pmid">16582903</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PT</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Kanca</surname><given-names>O</given-names></name><name><surname>Lin</surname><given-names>WW</given-names></name><name><surname>Schulze</surname><given-names>KL</given-names></name><name><surname>Li-Kroeger</surname><given-names>D</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Devereaux</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>V</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Ge</surname><given-names>M</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Housden</surname><given-names>BE</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Levis</surname><given-names>RW</given-names></name><name><surname>Spradling</surname><given-names>AC</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A gene-specific T2A-GAL4 library for <italic>Drosophila</italic></article-title><source>eLife</source><volume>7</volume><elocation-id>e35574</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35574</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Kolluru</surname><given-names>SS</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>Gardeux</surname><given-names>V</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>David</surname><given-names>FPA</given-names></name><name><surname>Brbić</surname><given-names>M</given-names></name><name><surname>Spanier</surname><given-names>K</given-names></name><name><surname>Leskovec</surname><given-names>J</given-names></name><name><surname>McLaughlin</surname><given-names>CN</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Jones</surname><given-names>RC</given-names></name><name><surname>Brueckner</surname><given-names>K</given-names></name><name><surname>Shim</surname><given-names>J</given-names></name><name><surname>Tattikota</surname><given-names>SG</given-names></name><name><surname>Schnorrer</surname><given-names>F</given-names></name><name><surname>Rust</surname><given-names>K</given-names></name><name><surname>Nystul</surname><given-names>TG</given-names></name><name><surname>Carvalho-Santos</surname><given-names>Z</given-names></name><name><surname>Ribeiro</surname><given-names>C</given-names></name><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Mahadevaraju</surname><given-names>S</given-names></name><name><surname>Przytycka</surname><given-names>TM</given-names></name><name><surname>Allen</surname><given-names>AM</given-names></name><name><surname>Goodwin</surname><given-names>SF</given-names></name><name><surname>Berry</surname><given-names>CW</given-names></name><name><surname>Fuller</surname><given-names>MT</given-names></name><name><surname>White-Cooper</surname><given-names>H</given-names></name><name><surname>Matunis</surname><given-names>EL</given-names></name><name><surname>DiNardo</surname><given-names>S</given-names></name><name><surname>Galenza</surname><given-names>A</given-names></name><name><surname>O’Brien</surname><given-names>LE</given-names></name><name><surname>Dow</surname><given-names>JAT</given-names></name><name><surname>Jasper</surname><given-names>H</given-names></name><name><surname>Oliver</surname><given-names>B</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Deplancke</surname><given-names>B</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>D</given-names></name><name><surname>Ahmed-Braimah</surname><given-names>Y</given-names></name><name><surname>Arbeitman</surname><given-names>M</given-names></name><name><surname>Ariss</surname><given-names>MM</given-names></name><name><surname>Augsburger</surname><given-names>J</given-names></name><name><surname>Ayush</surname><given-names>K</given-names></name><name><surname>Baker</surname><given-names>CC</given-names></name><name><surname>Banisch</surname><given-names>T</given-names></name><name><surname>Birker</surname><given-names>K</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Bolival</surname><given-names>B</given-names></name><name><surname>Brantley</surname><given-names>SE</given-names></name><name><surname>Brill</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>NC</given-names></name><name><surname>Buehner</surname><given-names>NA</given-names></name><name><surname>Cai</surname><given-names>XT</given-names></name><name><surname>Cardoso-Figueiredo</surname><given-names>R</given-names></name><name><surname>Casares</surname><given-names>F</given-names></name><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Clandinin</surname><given-names>TR</given-names></name><name><surname>Crasta</surname><given-names>S</given-names></name><name><surname>Desplan</surname><given-names>C</given-names></name><name><surname>Detweiler</surname><given-names>AM</given-names></name><name><surname>Dhakan</surname><given-names>DB</given-names></name><name><surname>Donà</surname><given-names>E</given-names></name><name><surname>Engert</surname><given-names>S</given-names></name><name><surname>Floc’hlay</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>N</given-names></name><name><surname>González-Segarra</surname><given-names>AJ</given-names></name><name><surname>Groves</surname><given-names>AK</given-names></name><name><surname>Gumbin</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Harris</surname><given-names>DE</given-names></name><name><surname>Heifetz</surname><given-names>Y</given-names></name><name><surname>Holtz</surname><given-names>SL</given-names></name><name><surname>Horns</surname><given-names>F</given-names></name><name><surname>Hudry</surname><given-names>B</given-names></name><name><surname>Hung</surname><given-names>R-J</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name><name><surname>Jaszczak</surname><given-names>JS</given-names></name><name><surname>Jefferis</surname><given-names>GSXE</given-names></name><name><surname>Karkanias</surname><given-names>J</given-names></name><name><surname>Karr</surname><given-names>TL</given-names></name><name><surname>Katheder</surname><given-names>NS</given-names></name><name><surname>Kezos</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>AA</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kockel</surname><given-names>L</given-names></name><name><surname>Konstantinides</surname><given-names>N</given-names></name><name><surname>Kornberg</surname><given-names>TB</given-names></name><name><surname>Krause</surname><given-names>HM</given-names></name><name><surname>Labott</surname><given-names>AT</given-names></name><name><surname>Laturney</surname><given-names>M</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><name><surname>Leinwand</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>JSS</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Litovchenko</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H-H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>T-C</given-names></name><name><surname>Manning</surname><given-names>J</given-names></name><name><surname>Mase</surname><given-names>A</given-names></name><name><surname>Matera-Vatnick</surname><given-names>M</given-names></name><name><surname>Matias</surname><given-names>NR</given-names></name><name><surname>McDonough-Goldstein</surname><given-names>CE</given-names></name><name><surname>McGeever</surname><given-names>A</given-names></name><name><surname>McLachlan</surname><given-names>AD</given-names></name><name><surname>Moreno-Roman</surname><given-names>P</given-names></name><name><surname>Neff</surname><given-names>N</given-names></name><name><surname>Neville</surname><given-names>M</given-names></name><name><surname>Ngo</surname><given-names>S</given-names></name><name><surname>Nielsen</surname><given-names>T</given-names></name><name><surname>O’Brien</surname><given-names>CE</given-names></name><name><surname>Osumi-Sutherland</surname><given-names>D</given-names></name><name><surname>Özel</surname><given-names>MN</given-names></name><name><surname>Papatheodorou</surname><given-names>I</given-names></name><name><surname>Petkovic</surname><given-names>M</given-names></name><name><surname>Pilgrim</surname><given-names>C</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name><name><surname>Reisenman</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>EN</given-names></name><name><surname>dos Santos</surname><given-names>G</given-names></name><name><surname>Scott</surname><given-names>K</given-names></name><name><surname>Sherlekar</surname><given-names>A</given-names></name><name><surname>Shiu</surname><given-names>P</given-names></name><name><surname>Sims</surname><given-names>D</given-names></name><name><surname>Sit</surname><given-names>RV</given-names></name><name><surname>Slaidina</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>HE</given-names></name><name><surname>Sterne</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>Y-H</given-names></name><name><surname>Sutton</surname><given-names>D</given-names></name><name><surname>Tamayo</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Tastekin</surname><given-names>I</given-names></name><name><surname>Treiber</surname><given-names>C</given-names></name><name><surname>Vacek</surname><given-names>D</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Waddell</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wilson</surname><given-names>RI</given-names></name><name><surname>Wolfner</surname><given-names>MF</given-names></name><name><surname>Wong</surname><given-names>Y-CE</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Yoda</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Zinzen</surname><given-names>RP</given-names></name><collab>FCA Consortium§</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Fly Cell Atlas: A single-nucleus transcriptomic atlas of the adult fruit fly</article-title><source>Science</source><volume>375</volume><elocation-id>eabk2432</elocation-id><pub-id pub-id-type="doi">10.1126/science.abk2432</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Potter</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Editing transgenic DNA components by inducible gene replacement in <italic>Drosophila melanogaster</italic></article-title><source>Genetics</source><volume>203</volume><fpage>1613</fpage><lpage>1628</lpage><pub-id pub-id-type="doi">10.1534/genetics.116.191783</pub-id><pub-id pub-id-type="pmid">27334272</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masucci</surname><given-names>JD</given-names></name><name><surname>Miltenberger</surname><given-names>RJ</given-names></name><name><surname>Hoffmann</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Pattern-specific expression of the <italic>Drosophila</italic> decapentaplegic gene in imaginal disks is regulated by 3’ cis-regulatory elements</article-title><source>Genes &amp; Development</source><volume>4</volume><fpage>2011</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1101/gad.4.11.2011</pub-id><pub-id pub-id-type="pmid">2177439</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matinyan</surname><given-names>N</given-names></name><name><surname>Karkhanis</surname><given-names>MS</given-names></name><name><surname>Gonzalez</surname><given-names>Y</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Saltzman</surname><given-names>A</given-names></name><name><surname>Malovannaya</surname><given-names>A</given-names></name><name><surname>Sarrion-Perdigones</surname><given-names>A</given-names></name><name><surname>Dierick</surname><given-names>HA</given-names></name><name><surname>Venken</surname><given-names>KJT</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Multiplexed drug-based selection and counterselection genetic manipulations in <italic>Drosophila</italic></article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109700</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109700</pub-id><pub-id pub-id-type="pmid">34525356</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>J-Q</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Czech</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Holderbaum</surname><given-names>L</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Shim</surname><given-names>H-S</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Handler</surname><given-names>D</given-names></name><name><surname>Karpowicz</surname><given-names>P</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Booker</surname><given-names>M</given-names></name><name><surname>Brennecke</surname><given-names>J</given-names></name><name><surname>Perkins</surname><given-names>LA</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A genome-scale shRNA resource for transgenic RNAi in <italic>Drosophila</italic></article-title><source>Nature Methods</source><volume>8</volume><fpage>405</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1592</pub-id><pub-id pub-id-type="pmid">21460824</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>LA</given-names></name><name><surname>Holderbaum</surname><given-names>L</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Sopko</surname><given-names>R</given-names></name><name><surname>McCall</surname><given-names>K</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Shim</surname><given-names>H-S</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Housden</surname><given-names>A</given-names></name><name><surname>Foos</surname><given-names>M</given-names></name><name><surname>Randkelv</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>C</given-names></name><name><surname>Namgyal</surname><given-names>P</given-names></name><name><surname>Villalta</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Huan-Huan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fujiyama</surname><given-names>A</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Ayers</surname><given-names>K</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Czech</surname><given-names>B</given-names></name><name><surname>Neumuller</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Cavallaro</surname><given-names>A</given-names></name><name><surname>Hibbard</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Cooley</surname><given-names>L</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><name><surname>Parks</surname><given-names>A</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>J-Q</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The transgenic RNAi project at harvard medical school: resources and validation</article-title><source>Genetics</source><volume>201</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.180208</pub-id><pub-id pub-id-type="pmid">26320097</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>BD</given-names></name><name><surname>Ngo</surname><given-names>T-TB</given-names></name><name><surname>Hibbard</surname><given-names>KL</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>Jenett</surname><given-names>A</given-names></name><name><surname>Truman</surname><given-names>JW</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Refinement of tools for targeted gene expression in <italic>Drosophila</italic></article-title><source>Genetics</source><volume>186</volume><fpage>735</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1534/genetics.110.119917</pub-id><pub-id pub-id-type="pmid">20697123</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Port</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Bullock</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>111</volume><fpage>E2967</fpage><lpage>E2976</lpage><pub-id pub-id-type="doi">10.1073/pnas.1405500111</pub-id><pub-id pub-id-type="pmid">25002478</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Port</surname><given-names>F</given-names></name><name><surname>Boutros</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tissue-specific CRISPR-Cas9 screening in <italic>Drosophila</italic></article-title><source>Methods in Molecular Biology</source><volume>2540</volume><fpage>157</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-2541-5_7</pub-id><pub-id pub-id-type="pmid">35980577</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>CJ</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Russler</surname><given-names>EV</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Q system: a repressible binary system for transgene expression, lineage tracing, and mosaic analysis</article-title><source>Cell</source><volume>141</volume><fpage>536</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.025</pub-id><pub-id pub-id-type="pmid">20434990</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>CJ</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Using the Q system in <italic>Drosophila melanogaster</italic></article-title><source>Nature Protocols</source><volume>6</volume><fpage>1105</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.347</pub-id><pub-id pub-id-type="pmid">21738124</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riabinina</surname><given-names>O</given-names></name><name><surname>Luginbuhl</surname><given-names>D</given-names></name><name><surname>Marr</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>MN</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Potter</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Improved and expanded Q-system reagents for genetic manipulations</article-title><source>Nature Methods</source><volume>12</volume><fpage>219</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3250</pub-id><pub-id pub-id-type="pmid">25581800</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riabinina</surname><given-names>O</given-names></name><name><surname>Potter</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Q-system: a versatile expression system for <italic>Drosophila</italic></article-title><source>Methods in Molecular Biology</source><volume>1478</volume><fpage>53</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6371-3_3</pub-id><pub-id pub-id-type="pmid">27730575</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>J</given-names></name><name><surname>Mukherjee</surname><given-names>T</given-names></name><name><surname>Mondal</surname><given-names>BC</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>GC</given-names></name><name><surname>Wijewarnasuriya</surname><given-names>DP</given-names></name><name><surname>Banerjee</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Olfactory control of blood progenitor maintenance</article-title><source>Cell</source><volume>155</volume><fpage>1141</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.10.032</pub-id><pub-id pub-id-type="pmid">24267893</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Tirian</surname><given-names>L</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The VT GAL4, LexA, and Split-GAL4 driver line collections for targeted expression in the <italic>Drosophila</italic></article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/198648</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venken</surname><given-names>KJT</given-names></name><name><surname>Schulze</surname><given-names>KL</given-names></name><name><surname>Haelterman</surname><given-names>NA</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Evans-Holm</surname><given-names>M</given-names></name><name><surname>Carlson</surname><given-names>JW</given-names></name><name><surname>Levis</surname><given-names>RW</given-names></name><name><surname>Spradling</surname><given-names>AC</given-names></name><name><surname>Hoskins</surname><given-names>RA</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MiMIC: a highly versatile transposon insertion resource for engineering <italic>Drosophila melanogaster</italic> genes</article-title><source>Nature Methods</source><volume>8</volume><fpage>737</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1662</pub-id><pub-id pub-id-type="pmid">21985007</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendler</surname><given-names>F</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Galasso</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>KR</given-names></name><name><surname>Awan</surname><given-names>I</given-names></name><name><surname>Sudarikova</surname><given-names>Y</given-names></name><name><surname>Bustamante-Sequeiros</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Sung</surname><given-names>EY-H</given-names></name><name><surname>Aisa-Bonoko</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Baena-Lopez</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A LexAop &gt; UAS &gt; QUAS trimeric plasmid to generate inducible and interconvertible <italic>Drosophila</italic> overexpression transgenes</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>3835</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-07852-7</pub-id><pub-id pub-id-type="pmid">35264662</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of hunger-driven behaviors by neural ribosomal S6 kinase in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>102</volume><fpage>13289</fpage><lpage>13294</lpage><pub-id pub-id-type="doi">10.1073/pnas.0501914102</pub-id><pub-id pub-id-type="pmid">16150727</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname><given-names>R</given-names></name><name><surname>Mayer</surname><given-names>F</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Refined LexA transactivators and their use in combination with the <italic>Drosophila</italic> Gal4 system</article-title><source>PNAS</source><volume>107</volume><fpage>16166</fpage><lpage>16171</lpage><pub-id pub-id-type="doi">10.1073/pnas.1005957107</pub-id><pub-id pub-id-type="pmid">20805468</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Colbeth</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Ewen-Campen</surname><given-names>B</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Vogt</surname><given-names>E</given-names></name><name><surname>VanNest</surname><given-names>S</given-names></name><name><surname>Cavers</surname><given-names>C</given-names></name><name><surname>Villalta</surname><given-names>C</given-names></name><name><surname>Comjean</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Ayisi</surname><given-names>L</given-names></name><name><surname>Ragoowansi</surname><given-names>H</given-names></name><name><surname>Fenton</surname><given-names>E</given-names></name><name><surname>Efrem</surname><given-names>S</given-names></name><name><surname>Parks</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Perkins</surname><given-names>L</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Large-scale transgenic <italic>Drosophila</italic> resource collections for loss- and gain-of-function studies</article-title><source>Genetics</source><volume>214</volume><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302964</pub-id><pub-id pub-id-type="pmid">32071193</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94073.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>New York University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study reports the generation of genetic tools for manipulating several tissues at the same time in <italic>Drosophila</italic>. The authors provide <bold>convincing</bold> evidence that this allows for the generation of LexA and QF2 driver lines, which will be of great utility for understanding inter-organ communication. Making the tools available through the <italic>Drosophila</italic> stock center and plasmid depository will ensure that they are easily accessed by many researchers.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94073.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>&quot;Expanding the <italic>Drosophila</italic> toolkit for dual control of gene expression&quot; by Zirin et al. aims to develop resources for simultaneous independent manipulation of multiple genes in <italic>Drosophila</italic>. The authors use CRISPR knock-ins to establish a collection of T2A-LexA and T2A-QF2 transgenes with expression patterns in a number of commonly studied organs and tissues. In addition to the transgenic lines that are established, the authors describe a number of plasmids that can be used to generate additional transgenes, including a plasmid to generate a dual insert of LexA and QF that can be resolved into a single insert using FLP/FRT-mediated recombination, and plasmids to generate RNAi reagents for the LexA and QF systems. Finally, the authors demonstrate that a subset of the LexA and QF lines that they generated can induce RNAi phenotypes when paired with LexAop or QUAS shRNA lines. In general, the claims of the paper are well supported by the evidence and the authors do a thorough job of validating the transgenic lines and characterizing their expression patterns.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94073.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Zirin, Jusiak, and Lopes et al presented an efficient pipeline for making LexA-GAD and QF2 drivers. The tools can be combined with a large collection of existing GAL4 drivers for a dual genetic control of two cell populations. This is essential when studying inter-organ communications since most of the current genetic drivers are biased toward the expression of the central nervous system. In this manuscript, the authors described the methodology for efficiently generating T2A-LexA-GAD and T2A-QF2 knock-ins by CRISPR, targeting a number of genes with known tissue-specific expression patterns. The authors then validated and compared the expression of double as well as single drivers and found the tissue-specific expression results were largely consistent as expected. Finally, a collection of plasmids for LexA-GAD and QF,2 as well as the corresponding LexAop and QUAS plasmids were generated to facilitate the expansion of these tool kits. In general, this study will be of considerable interest to the fly community and the resources can be readily generalized to make drivers for other genes. I believe this toolkit will have a significant, immediate impact on the fly community.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94073.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zirin</surname><given-names>Jonathan</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jusiak</surname><given-names>Barbara</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, Irvine</institution><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Raphael</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ewen-Campen</surname><given-names>Benjamin</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bosch</surname><given-names>Justin A</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard University</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Risbeck</surname><given-names>Alexandria</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Forman</surname><given-names>Corey</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Villalta</surname><given-names>Christians</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Yanhui</given-names></name><role specific-use="author">Author</role><aff><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Perrimon</surname><given-names>Norbert</given-names></name><role specific-use="author">Author</role><aff><institution>Howard Hughes Medical Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>&quot;Expanding the <italic>Drosophila</italic> toolkit for dual control of gene expression&quot; by Zirin et al. aims to develop resources for simultaneous independent manipulation of multiple genes in <italic>Drosophila</italic>. The authors use CRISPR knock-ins to establish a collection of T2A-LexA and T2A-QF2 transgenes with expression patterns in a number of commonly studied organs and tissues. In addition to the transgenic lines that are established, the authors describe a number of plasmids that can be used to generate additional transgenes, including a plasmid to generate a dual insert of LexA and QF that can be resolved into a single insert using FLP/FRT-mediated recombination, and plasmids to generate RNAi reagents for the LexA and QF systems. Finally, the authors demonstrate that a subset of the LexA and QF lines that they generated can induce RNAi phenotypes when paired with LexAop or QUAS shRNA lines. In general, the claims of the paper are well supported by the evidence and the authors do a thorough job of validating the transgenic lines and characterizing their expression patterns.</p><p>Strengths:</p><list list-type="bullet"><list-item><p>Numerous Gal4 lines allow for highly specific genetic manipulation in a wide range of organs and tissues, however, similar tissue-specific drivers using alternative binary expression systems are not currently well developed. This study provides a large number of tissue and organ-specific LexA and QF2 driver lines that should be broadly useful for the <italic>Drosophila</italic> community.</p></list-item></list><list list-type="bullet"><list-item><p>While a minority of the driver lines do not express the expected pattern (likely due to cryptic regulatory elements in the LexA or QF2 sequences), the ability to generate drivers using two different Gal4 alternatives mitigates this issue (as in nearly all cases at least one of the two systems produces a clean driver line with the expected expression pattern).</p></list-item></list><list list-type="bullet"><list-item><p>The use of LexA-GAD provides an additional degree of control as it is subject to Gal80 repression. This could prove to be particularly useful in cases where a researcher wishes to manipulate multiple genes using Gal4 and LexA-GAD drivers as the Gal80(ts) system could be used for simultaneous temporal control of both constructs.</p></list-item></list><list list-type="bullet"><list-item><p>The use of Fly Cell Atlas information to generate novel oenocyte-specific driver lines provides a useful proof-of-concept for constructing additional highly tissue-specific drivers.</p></list-item></list><p>Weaknesses:</p><list list-type="bullet"><list-item><p>Since these reagents will most commonly be paired with existing Gal4 lines, adding information about corresponding Gal4 lines targeting these tissues and how faithfully the LexA and QF2 lines recapitulate these Gal4 patterns would be highly beneficial.</p></list-item></list></disp-quote><p>It is outside the scope of this paper to analyze the expression patterns of the corresponding publicly available Gal4 lines. It is clear from the tissue specificity of the LexA-GAD and QF2 lines that they are expressed in the expected larval tissues based on the target genes. We have added a sentence in the discussion section noting “Further, we expect that there will also be differences between the expression pattern of corresponding Gal4 and the LexA-GAD/QF lines, as the latter were made by knock-in, while the former are often enhancer traps. However, based on our larval mounts and dissections, the stocks generated in this paper are highly specific to the expression pattern of the targeted genes.”</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>It is not stated in the manuscript if these transgenic lines and plasmids are currently publicly available. Information about how to obtain these reagents through Bloomington, Addgene, or TRiP should be added to the manuscript.</p></list-item></list></disp-quote><p>We have added to the materials section that “All vectors described here that are required to produce new driver lines will be made available at Addgene.” And “All transgenic fly stocks described here will be made available at the Bloomington <italic>Drosophila</italic> Stock Center.”</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Zirin, Jusiak, and Lopes et al presented an efficient pipeline for making LexA-GAD and QF2 drivers. The tools can be combined with a large collection of existing GAL4 drivers for a dual genetic control of two cell populations. This is essential when studying inter-organ communications since most of the current genetic drivers are biased toward the expression of the central nervous system. In this manuscript, the authors described the methodology for efficiently generating T2A-LexA-GAD and T2A-QF2 knock-ins by CRISPR, targeting a number of genes with known tissue-specific expression patterns. The authors then validated and compared the expression of double as well as single drivers and found the tissue-specific expression results were largely consistent as expected. Finally, a collection of plasmids for LexA-GAD and QF,2 as well as the corresponding LexAop and QUAS plasmids were generated to facilitate the expansion of these tool kits. In general, this study will be of considerable interest to the fly community and the resources can be readily generalized to make drivers for other genes. I believe this toolkit will have a significant, immediate impact on the fly community.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><list list-type="bullet"><list-item><p>Lines 56-57: Janelia Flylight lines are not necessarily brain-specific - this collection has or could be screened in other tissues.</p></list-item></list></disp-quote><p>Correct. We have altered this sentence to read: However, these lines were developed primarily for brain expression. Although they are often expressed in other tissues, they are not well suited for experiments targeting non-neuronal cell types</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Line 197 - I don't see the referenced Figure S1 in the reviewer materials. It appears this is actually referencing panels LL and MM in Figure 2.</p></list-item></list></disp-quote><p>Correct. We have fixed this error.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>No information on the injection efficiency to create the CRISPR knock-in lines is presented. I am guessing the efficiency will be similar to that of other reported HDR-based CRISPR knock-ins, but if this information is available it would be useful to include it so that others know what to expect when injecting these vectors.</p></list-item></list></disp-quote><p>We did not systematically assay the injection efficiency. However, we can say that it was in line with previous descriptions of CRISPR-based plasmid and ‘drop-in’ HDR methods. We have added a note in the methods that “Knock-in efficiencies were comparable to previous reports (Kanca et al. 2019; Kanca et al. 2022).”</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Demonstration of successful multi-manipulation would strengthen the paper.</p></list-item></list></disp-quote><p>We do not feel that this is necessary as there have been many papers showing combinatorial Gal4+LexA/QF experiments. An example from our lab can be seen in PMID: 37582831.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Also, are there approaches for efficiently constructing pairs of UAS/LexAOp or UAS/QUAS shRNA lines that would potentially streamline the genetics for multi-manipulation? Otherwise, this could be rather cumbersome to implement as one needs to combine a Gal4 line, a LexA/QF2 line (which will be constrained as to its chromosomal location by the target gene), and separate UAS-shRNA and LexAop/QUAS-shRNA constructs into the same fly.</p></list-item></list></disp-quote><p>There are some recent innovations that are useful in this respect. We have added a sentence to the discussion that says: “There remains an unmet need for a single vector that would allow for UAS/LexAop/QUAS control of different shRNAs. However, recent innovations in multi module vectors and multiplexed drug-based genetics allow researchers to more efficiently generate UAS/QUAS/lexAop transgenic fly strains (Matinyan et al. 2021; Wendler et al. 2022).”</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>In Figure 5 - is the difference for the hh inserts attributable to the driver line or the GFP/mCherry construct (or differential ability to detect GFP/mCherry)? One could try visualizing hhL(-Q) with the LexAop-GFP line. I guess that the correspondence between the nubbin and hh result suggests that maybe QF2 is suppressed in the wing pouch, but this could also be the difference in the reporter constructs and it would be interesting to know if this difference is truly attributable to the driver constructs from the standpoint of knowing how consistent the QF/LexA patterns are expected to be.</p></list-item></list></disp-quote><p>The difference is not attributable to GFP versus mCherry or the specific LexAop and QUAS lines that we used in figure 5. We tested the double knock-in and derivative single knock-ins with various QUAS and lexAop reporters and always observed the same pattern.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>There are a few points that should be clarified. A list of these specific points is provided below with the view that this could help the preparations of a stronger, improved paper.</p><p>Line 50-51: &quot;There have been no systematic studies comparing the two systems, with only anecdotal evidence to support one system over the other.&quot; It is unclear to me what the anecdotal evidence the authors referred to. Could the authors elaborate more on this part?</p></disp-quote><p>Based on an examination of QUAS brains, Potter et al, 2010 (PMID 20434990) makes the claim that “The low basal expression of QUAS and UAS reporters provides significant advantage compared to the lexA binary expression system.”</p><p>Shearin et al., 2014 (PMID: 24451596) compared Gal4/UAS, LexA/LexAop, and QF/QUAS reporter strength with the nompC driver and found that the QF system produced the strongest expression.</p><p>While these observations might be true in the nervous system, it isn’t clear that this extends to other tissues, nor what effect this would have on gene knockdown experiments.</p><p>There have been some reports that have explored swapping out a Gal4 insertion for a LexA or QF at the same locus. For example, Gohl et al. 2011 PMID: (PMID 21473015) mentions that “the majority of the swaps captured most features of the original GAL4 expression patterns. In some cases, however, either prominent features of the GAL4 pattern were lost or we observed new expression patterns. These changes may have resulted from differences in the strength or responsiveness of reporter lines. Alternately, the swap may have modified some combination of enhancer spacing and sequence composition flanking the promoter.”</p><disp-quote content-type="editor-comment"><p>Line 61-62: &quot;On average, each StanEx line expresses LexA activity in five distinct cell types, with only one line showing expression in just one tissue...&quot; What's the evidence to support this claim?</p></disp-quote><p>This observation comes from Figure S3 of Kockel et al. 2016 (PMID: 27527793), where the authors “analyzed a subset of 76 StanEx lines that are unambiguously inserted within, or adjacent to, a single known gene.” We cited this reference in the preceding sentence. To clarify, we have added the citation again for line 61-62.</p><disp-quote content-type="editor-comment"><p>Line 63-65: &quot;These findings are consistent with prior studies indicating that enhancers very rarely produce expression patterns that are limited to a single cell type in a complex organism (Jenett et al. 2012).&quot; It might be worth expanding on the use of the split system to achieve high cell-type-specificity. Especially, there are growing resources using split-intein and T2A-split-GAL4 with the prediction of genes from single-cell RNA sequencing datasets.</p></disp-quote><p>We agree that the split system is currently the premier method to produce the most specific driver lines. Indeed, our group has recently published a paper on the split-intein Gal4 system (see PMID 37276389). However, the tradeoff is that split systems usually require generation of transgenic lines, which becomes impractical for research involving two independent binary transcriptional systems, as the user would need to combine at least three driver components into single stocks, plus the UAS/QUAS/LexAop insertions. The ideal would be to generate complementary split insertions on the same chromosome, but we think a discussion of this is tangential to the thrust of our work here.</p><disp-quote content-type="editor-comment"><p>The authors did not fully discuss the rationale of using LexA-GAD vs LexA-p65 or VP16AD throughout the manuscript. I assumed the main reason for choosing LexA-GAD was to be compatible with GAL80 suppression. It might be worth explicitly stating in the result (e.g., line 123 or in the introduction). Also, did the authors observe weak transcriptional activation using LexA-GAD? It has been shown that the strength of transactional activation is much weaker for GAL4AD than the p65 or VP16AD. This might be worth noting in the manuscript as well.</p></disp-quote><p>We did briefly mention in the introduction that one disadvantage of the Flylight lines is that they “use a p65 transcriptional activation domain and therefore are not compatible with the Gal80 temperature sensitive Gal4 repression system.” We have expanded on this issue in the introduction which now says: “We chose to use LexA with the Gal4 activation domain, rather than the p65 or VP16 activation domains to allow for temporal control by Gal80 (Lai and Lee 2006; Pfeiffer et al. 2010). We chose to use QF2 variant over the original QF, to avoid the toxicity reported for the latter (Riabinina et al. 2015).”</p><p>We did not have any problems visualizing gene expression with fluorescent reporters. Nor did we have any difficulty obtaining knock-down phenotypes with ubiquitous drivers.</p><disp-quote content-type="editor-comment"><p>Line 125-127. Is there a specific reason why the authors chose the SV40 terminator for the double driver construct but the Hsp70 terminator for the single driver construct?</p></disp-quote><p>We found that the Hsp70 terminator gave slightly lower expression and decided to use this for the singles to avoid toxicity. For the doubles we chose the SV40, to compensate for reduced protein expressiojn of the second gene position.</p><disp-quote content-type="editor-comment"><p>Line 144-146: &quot;To verify the knock-ins, we PCR-amplified the genomic regions flanking the insertion sites and confirmed that the insertions were seamless and in-frame.&quot; Did the authors recover lines with indel introduced, resulting in out-of-frame insertion?</p></disp-quote><p>Yes, we did see indels, which sometimes resulted in out of frame insertions, which were discarded. This result is in line with what we have observed with other CRISPR HDR knock-in experiments.</p><disp-quote content-type="editor-comment"><p>The underlying reason might be out of the scope of this manuscript. However, it would still be helpful for the authors to speculate the potential reasons why the T2A-LexA-GAD and T2A-QF2 targeting the same insertion site showed very distinct expressions.</p></disp-quote><p>It is outside the scope of this report to test this issue experimentally. We have a section in the discussion which does speculate as to the reason: “While we had no difficulty obtaining knock-ins for both types of activators, we did observe that for some target genes, the T2A-QF2 was only active in a subset of the expected gene expression pattern. In particular, we found that T2A-QF2 was difficult to express in the wing pouch. It may be that toxicity is an issue, and the weaker QF2w may be a better option for generating drivers in some organs (Riabinina and Potter 2016). Alternatively, differences in the LexA-GAD and QF2 sequences, and sequence length, could impact the function of nearby gene regulatory regions.”</p><disp-quote content-type="editor-comment"><p>Regarding the observation that the existence of 3XP3-RFP marker can interfere with the expression of T2A-LexA-GAD and T2A-QF2 expression in a case-by-case manner, it might be worth emphasizing in the discussion that the proper removal of 3XP3-RFP marker by Cre/LoxP recombination is important.</p></disp-quote><p>We have added the following to the discussion: “Importantly, our knock-in constructs contain the 3XP3-RFP cassette for screening transformants. Perhaps due to interaction between the 3XP3 promoter and the regulatory regions of the target gene, we occasionally saw misexpression of the LexA-GAD/QF2 in the 3XP3 domain. We have therefore prioritized Cre-Lox removal of the 3XP3-RFP cassette from our knock-in stocks, and advise that users of the plasmids described here likewise remove the marker, following successful knock-in.”</p><disp-quote content-type="editor-comment"><p>For Fig. 5B, 5F-G, the authors should elaborate more in the result section. For example, lines 215-217:&quot;We tested this with the hh and dpp lines and observed robust generation of both T2A-QF2 and T2A-LexA-GAD from hs-Flp; T2A-QF2-T2A-LexA-GAD parents (Figure 5B).&quot; It is unclear what the authors mean by &quot;robust generation&quot;. Also, there is no description of the results in Fig. 5F-G.</p></disp-quote><p>We have expanded this section for figure 5B, which now reads: “We tested this with the hh and dpp lines and observed robust generation of both T2A-QF2 and T2A-LexA-GAD from hs-Flp; T2A-QF2-T2A-LexA-GAD parents (Figure 5B). In the case of the hh line, 15 out of 36 heat-shocked parents gave rise to at least one T2A-LexA-GAD progeny, with a mean of 14% recombinant offspring per parent. 20 out of 36 gave rise to at least one T2A-QF2 progeny, with a mean of 9% recombinant offspring per parent. In the case of the dpp line, 31 out of 32 heat-shocked parents gave rise to at least one T2A-LexA-GAD progeny, with a mean of 30% recombinant offspring per parent. 17 out of 32 gave rise to at least one T2A-QF2 progeny, with a mean of 9% recombinant offspring per parent.</p><p>We have also added a description for Figure 5F-G, which reads: “Recombinants were also independently verified by PCR of the insertions (Figure 5F-G), where we observed the expected smaller band sizes in the derivative T2A-QF2 and T2A-LexA-GAD relative to the parental double driver.”</p><disp-quote content-type="editor-comment"><p>Line 229, minor error: &quot;Into these vectors, ...&quot;</p></disp-quote><p>We have edited this to read: “We cloned shRNAs targeting forked (f) and ebony (e) genes into these vectors and assayed their phenotypes when crossed to ubiquitous LexA-GAD and QF2 drivers.”</p><disp-quote content-type="editor-comment"><p>Line 238-240: &quot;Both Tub-LexA-GAD and Tub-QF2 drivers generated knockdown phenotypes in the thorax when crossed to f and e shRNA lines. However, the Tub-LexA-GAD phenotypes were stronger than those of Tub-QF2 (Figure 6C-D, F-G, I-J).&quot; The stated &quot;stronger phenotypes&quot; are not clear to me. It might be worth elaborating more.</p></disp-quote><p>We have further clarified this by changing it to: “However, the Tub-LexA-GAD phenotypes were stronger than those of Tub-QF2 (Figure 6C-D, F-G, I-J). For example, Tub-LexA-GAD produced a fully penetrant f bristle phenotype (Figure 6F) while some wild-type bristles remained on the thoraces of Tub-QF2 f knockdown (Figure 6G). Neither Tub-LexA-GAD or Tub-QF2 was able to achieve the strength of phenotype generated by the T2A-LexA-GAD da knock-in line (compare the darkness of the cuticle caused by e knockdown in Figure 6H-J).”</p><disp-quote content-type="editor-comment"><p>Line 257-250: &quot;Our collection of T2A-LexA-GAD and T2A-QF2 and double driver vectors can be easily adapted to target any gene for CRISPR knock-in, with a high probability that the resulting line will accurately reflect the expression of the endogenous locus&quot; The authors could refer to the recent gene-specific Trojan GAL4/split-GAL4 work to support the idea that these gene-specific T2A-GAL4/split-GAL4 drivers reflect better than the enhancer-based drivers.</p></disp-quote><p>We have added the following sentence to the discussion: “The specificity achieved with this approach can also be seen in recent efforts to build collections of gene specific T2A-Split-Gal4 and T2A-Gal4 insertions (Kanca et al. 2019; Chen et al. 2023; Ewen-Campen et al. 2023).”</p><disp-quote content-type="editor-comment"><p>Line 630: &quot;Removal of 3XP3-RFP eliminated gut and anal pad misexpression and did not affect glial cell expression.&quot; It would be helpful to add the annotation on Fig. 3B to show the location of glial cell expression.</p></disp-quote><p>We have added arrowheads on Figure 3 and the legend now reads: “Removal of 3XP3-RFP eliminated gut and anal pad misexpression and did not affect glial cell expression (white arrowheads).</p><disp-quote content-type="editor-comment"><p>Line 650-651: &quot;The fat body mCherry expression is also present in the reporter stock and does not indicate LexA-GAD activity.&quot; I did not get what the authors were trying to convey. Where did the fat body mCherry expression come from? Please elaborate more.</p></disp-quote><p>We have changed this section to explain that “The fat body mCherry expression (yellow arrowhead) is from leakiness of the reporter stock and does not indicate LexA-GAD activity.”</p><disp-quote content-type="editor-comment"><p>Line 679-680: &quot;forked shRNA produced a forked bristles phenotype.&quot; Please add the annotation on the figures to show where the phenotypes were.</p></disp-quote><p>We have added arrowheads and asterisks to the figure. The legend now reads: “(E-G) forked shRNA produced a forked bristles phenotype (white arrowheads). Note that some bristles retain a more elongated wild-type morphology with the Tub-QF2 driven forked knockdown (G, yellow asterisk).”</p><disp-quote content-type="editor-comment"><p>Fig 1D-E and 4A-B. There is no description throughout the manuscript about QA, QS regulation as well as little GAL80ts regulation. It will confuse readers with a little fly genetic background. Please include the introductions of these regulations of different binary expression systems.</p></disp-quote><p>We have added a section in the introduction, which states: “We chose to use LexA with the Gal4 activation domain, rather than the p65 or VP16 activation domains to allow for temporal control by the temperature sensitive Gal4 repressor, Gal80 (Lai and Lee 2006; Pfeiffer et al. 2010). We chose to use QF2 variant over the original QF, to avoid the toxicity reported for the latter (Riabinina et al. 2015). Like Gal80-based modulation of LexA-GAD, QF2 activity can also be regulated temporally by expressing QS, a QF repressor. QS repression of QF can be released by feeding flies quinic acid (Riabinina and Potter 2016).”</p><disp-quote content-type="editor-comment"><p>Fig. 2, there are several ND in the figure without any explanation in the manuscript (e.g. Mef2 and He). In addition, the expression patterns look quite different between T2A-LexA-GAD and T2A-QF2 for some genes (e.g., mex1, Myo31DF), but the authors did not mention any of them in the manuscript. Please elaborate more.</p></disp-quote><p>We have altered the Figure 2 legend as follows: “(A-KK) T2A-LexA-GAD knock-in lines crossed to a LexAop-GFP reporter and T2A-QF2 knock-in lines crossed to a QUAS-GFP reporter. Panels show 3rd instar larva. GFP shows the driver line expression pattern. RFP shows the 3XP3 transformation marker, which labels the posterior gut and anal pads of the larva. Gene names and tissues are on the left. We failed to obtain LexA-GAD knock-ins for Mef2 (E) and He (DD). (LL-MM) 3rd instar imaginal disc from the insertions in the nubbin (nub) gene. Note that most of the lines are highly tissue-specific and are comparable between the LexA-GAD and QF2 knock-ins. Insertions in the daughterless gene (da) and nub are an exception, as the T2A-LexA-GAD, but not the T2A-QF2, gives the expected expression pattern. Insertions in the gut-specific genes mex1 (X-Y) and Myo31Df (Z-AA) also differed between the LexA-GAD and QF2 drivers.”</p><p>We have also added a note on the inconsistency of mex1 and Myo31Df in the discussion: “While we had no difficulty obtaining knock-ins for both types of activators, we did observe that for some target genes, the T2A-QF2 was only active in a subset of the expected gene expression pattern. In particular, we found that T2A-QF2 was difficult to express in the wing pouch. Additionally, we found that the driver expression in the gut-specific genes, mex1 and Myo31Df differed between the LexA-GAD and QF2 transformants. In both cases the LexA-GAD was more broadly expressed along the length of the gut than the QF2. It may be that toxicity is an issue, and the weaker QF2w may be a better option for generating drivers in some organs (Riabinina and Potter 2016).”</p><disp-quote content-type="editor-comment"><p>Fig. 4B, it is unclear why the hsp70 is present downstream of the enhancer of interest (upstream of T2A). Is it the molecular mark resulting from the cloning steps? Does it serve any specific purpose?</p></disp-quote><p>This is the <italic>Drosophila</italic> hsp70 gene minimal promoter and is standard for many expression constructs in <italic>Drosophila</italic>. In the methods section we described how we made versions of the pMCS-T2A-QF2-T2A-LexA-GAD-WALIUM20 with and without tis minimal promoter: “We used pMCS-T2A-QF2-T2A-lexA0GAD-WALIUM20 for dpp-blk and pMCS-T2A-QF2-T2A-lexGAD-WALIUM20-alt (which lacks the hsp70 promoter) for Ilp2, since dpp-blk does not have a basal promoter, but the Ilp2 enhancer does.”</p><disp-quote content-type="editor-comment"><p>Fig 5A. The resulting single T2A-QF2 and T2A LexA-GAD from the double driver parental lines retain the sequence of FRT3 upstream of the QF2 and LexA-GAD. I assume the FRT3 part will be translated and remain attached to QF2 and LexA-GAD. Is that correct? If so, would this cause any adverse effect?</p></disp-quote><p>Correct. The FRT3 sequence is present in both the parental double and single derivatives. We can say that the additional amino acids do not prevent LexA-GAD or QF2 transcriptional activation. We do not know whether there may be other adverse effects, though we did not observe any.</p><disp-quote content-type="editor-comment"><p>Fig. 5C-C'. It seems like the images of Fig. 5C-C' were the same as Fig. 4D-D'. If so, the authors should indicate that in the figure legend.</p></disp-quote><p>We have made a note of this in the figure legend.</p></body></sub-article></article>